<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12217235</article-id><article-id pub-id-type="pmcid-ver">PMC12217235.1</article-id><article-id pub-id-type="pmcaid">12217235</article-id><article-id pub-id-type="pmcaiid">12217235</article-id><article-id pub-id-type="pmid">40594088</article-id><article-id pub-id-type="doi">10.1038/s41598-025-04064-7</article-id><article-id pub-id-type="publisher-id">4064</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Strictosamide and mitraphylline inhibit cancer cell motility by suppressing epithelial-mesenchymal transition via integrin &#945;4-mediated signaling</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Varl&#305;</surname><given-names initials="M">M&#252;cahit</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Lee</surname><given-names initials="K">Kyungha</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bach</surname><given-names initials="TT">Tran The</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Binh</surname><given-names initials="TD">Tran Duc</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kim</surname><given-names initials="H">Hangun</given-names></name><address><email>hangunkim@sunchon.ac.kr</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kang</surname><given-names initials="KB">Kyo Bin</given-names></name><address><email>kbkang@sookmyung.ac.kr</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043jqrs76</institution-id><institution-id institution-id-type="GRID">grid.412871.9</institution-id><institution-id institution-id-type="ISNI">0000 0000 8543 5345</institution-id><institution>College of Pharmacy, </institution><institution>Sunchon National University, </institution></institution-wrap>255 Jungang-ro, Suncheon-si, Jeollanam-do 57922 Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00vvvt117</institution-id><institution-id institution-id-type="GRID">grid.412670.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0729 3748</institution-id><institution>College of Pharmacy and Research Institute of Pharmaceutical Sciences, </institution><institution>Sookmyung Women&#8217;s University, </institution></institution-wrap>100 Cheongpa-ro 47 gil, Yongsan-gu, Seoul, 04310 Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02wsd5p50</institution-id><institution-id institution-id-type="GRID">grid.267849.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2105 6888</institution-id><institution>Institute of Ecology and Biological Resources, </institution><institution>Vietnam Academy of Science and Technology, </institution></institution-wrap>Ha Noi, Vietnam </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>22807</elocation-id><history><date date-type="received"><day>14</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>23</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>02</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-03 11:25:36.920"><day>03</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2025_Article_4064.pdf"/><abstract id="Abs1"><p id="Par1">Epithelial-mesenchymal transition (EMT) is a critical process in cancer cell motility and metastasis. Monoterpene indole alkaloids (MIAs) have been widely investigated for biological activities, but rarely been explored for cell motility inhibition. This study aimed to discover natural products, especially focusing on MIAs, that inhibit EMT in cancer cells, based on our screening using multiple plant extracts. We found that an extract of the aerial parts of <italic toggle="yes">Uncaria scandens</italic> (Sm.) Wall. (Rubiaceae) decreased cancer cell motility. Targeted isolation exhibited eight MIAs. Among them, strictosamide and mitraphylline suppressed the invasion and migration of the cells. The alteration of the mRNA expression of the EMT effectors and transcription factors suggested that the EMT signaling pathway is related to the suppression of cancer cell motility by both compounds. RT-PCR gene array suggested inhibition of integrin &#945;4 signaling as a potential mechanism of the EMT inhibition, which was supported by the quantitative analysis of the mRNA expressions of the related genes. Together, present study is the first report highlighting the cell motility-suppressive effects of strictosamide and mitraphylline. Our results suggested the potential applicability of strictosamide and mitraphylline for the prevention of metastasis.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-04064-7.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bioactivity-guided fractionation</kwd><kwd>Metastasis suppressor</kwd><kwd>Integrin &#913;4&#946;1 agonist</kwd><kwd>Vallesiachotaman-type alkaloid</kwd><kwd>Spirocylic oxindole alkaloid</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Cancer</kwd><kwd>Molecular medicine</kwd><kwd>Oncology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100007225</institution-id><institution>Ministry of Science and Technology</institution></institution-wrap></funding-source><award-id>&#272;T&#272;L.CN-72/22</award-id><principal-award-recipient><name name-style="western"><surname>Binh</surname><given-names>Tran Duc</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>RS-2024-00413760</award-id><award-id>NRF-2021K1A3A1A21038059</award-id><principal-award-recipient><name name-style="western"><surname>Kim</surname><given-names>Hangun</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Kyo Bin</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Cancer is more difficult to treat when metastasis occurs. Despite advances in treatment, metastasis is the most common cause of cancer-related deaths<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Epithelial-mesenchymal transition (EMT), a developmental process in which epithelial cells are transformed into spindle-shaped mesenchymal cells, enhances mobility, invasion, and resistance to apoptotic stimuli in cancer cells, which advances their metastatic properties<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. A fundamental event in EMT includes downregulation of the epithelial marker E-cadherin, whereas the expressions of mesenchymal markers, such as N-cadherin, vimentin, and fibronectin, are upregulated<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Several experimental studies have suggested that EMT inhibition can help prevent metastasis<sup><xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref></sup>. Hence, small molecules that target EMT may be valuable candidates as chemotherapeutic agents that reduce malignancy.</p><p id="Par3">Monoterpene indole alkaloids (MIAs) are phytochemicals derived from strictosidine which is biosynthesized by condensation of tryptamine and secologanin<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. MIAs exhibit structural complexity and diversity during subsequent biosynthetic pathway, and this diversity makes them a promising source of drug candidates<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. The most well-known clinical applications of MIAs are vinblastine and vincristine [chemotherapeutic agents from <italic toggle="yes">Catharanthus roseus</italic> (L.) G. Don (Apocynaceae)], reserpine [an antihypertensive drug from <italic toggle="yes">Rauvolfia serpentina</italic> (L.) Benth. ex Kurz (Apocynaceae)], and quinine [an antimalarial drug from <italic toggle="yes">Cinchona</italic> spp. (Rubiaceae)]. Despite extensive pharmacological investigations on MIAs, their inhibitory activities on cell motility remain unexplored.</p><p id="Par4">As a part of our research program aiming to discover natural products that suppress cancer cell motility<sup><xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref></sup>, we investigated the phytochemistry and pharmacology of aerial parts of <italic toggle="yes">Uncaria scandens</italic> (Sm.) Wall. (Rubiaceae). The genus <italic toggle="yes">Uncaria</italic> is a rich source of alkaloids, especially MIAs<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The species that have been well-characterized for their bioactive chemical constituents include <italic toggle="yes">Uncaria rhynchophylla</italic> (Miq.) Miq. and <italic toggle="yes">Uncaria tomentosa</italic> (Willd. ex Schult.) DC<sup><xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref></sup>. However, MIA constituents of <italic toggle="yes">U. scandens</italic> have rarely been investigated. Yang et al.<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> performed a chemical investigation of <italic toggle="yes">U. scandens</italic>; however, only triterpenes and flavonoids were reported. A study using liquid chromatography-tandem mass spectrometry (LC-MS/MS) profiling suggested the possible occurrence of MIAs in <italic toggle="yes">U. scandens</italic>; however, these were not fully confirmed by further experiments<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p><p id="Par5">Here, we describe the bioactivity- and chemical profile-guided discovery of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>), two MIAs isolated from <italic toggle="yes">U. scandens</italic>, as bioactive compounds against the motility of H1975, AGS, and CaCo2 cells, which are human lung, gastric, and colorectal cancer cells, respectively, via EMT suppression. The three cancer cells used in this study harbored different states of mutations in cancer-critical genes: AGS has mutant KRAS, PIK3CA, TP53, and CTNNB1; CaCo2 has wild-type KRAS, BRAF, and PIK3CA; and H1975 has mutant EGFR, PIK3CA, and TP53<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Plant materials</title><p id="Par6">The aerial parts of <italic toggle="yes">Uncaria scandens</italic> (Sm.) Wall. were collected on March 9, 2011, from the Dong community in K&#8217;Bang district, Gia Lai province, Vietnam. The plant was authenticated by T. T. Bach (Vietnam Academy of Science and Technology, Hanoi, Vietnam). A voucher specimen (VK 4455) was deposited in the herbarium of the Korea Research Institute of Bioscience and Biotechnology (Daejeon, Republic of Korea).</p></sec><sec id="Sec4"><title>Isolation and structural Elucidation of compounds</title><p id="Par7">The dried aerial parts of <italic toggle="yes">U. scandens</italic> (550&#160;g) were extracted with MeOH (3&#8201;&#215;&#8201;5.5&#160;L, for 2&#160;h each) by ultrasonication at room temperature. The crude extract (47.6&#160;g) was obtained by removing the extraction solvent <italic toggle="yes">in vacuo</italic>. The extract was suspended in H<sub>2</sub>O and washed with <italic toggle="yes">n</italic>-hexane to remove fat, wax, and chlorophyll. The aqueous residue was acidified using HCl to attain a pH of 2&#8211;3, and the nonpolar compounds were extracted from the acidic suspension using EtOAc. Thereafter, NH<sub>4</sub>OH was added to aqueous residue to obtain a pH of 11&#8211;12 and alkaloid-rich fraction (0.8&#160;g) was obtained by extracting it with CH<sub>2</sub>Cl<sub>2</sub>. Extra-pure grade solvents used for extraction and fractionation were purchased from Daejung Chemicals &amp; Metals Co. Ltd. (Si-heung, Korea). The total extract and fractions were desiccated with a nitrogen blower and a centrifugal vacuum evaporator before further chemical and biological analysis.</p><p id="Par8">Compound <bold>2</bold> (165.0&#160;mg) was obtained as a MeOH-insoluble pellet of the alkaloid-rich fraction during sample preparation for the preparative HPLC. The remaining alkaloid-rich fraction was separated using preparative HPLC (Waters 600 system) equipped with a Hector C<sub>18</sub> column (250&#8201;&#215;&#8201;21.2&#160;mm, 5&#160;&#956;m, RS Tech, Daejeon, Korea) and eluted with a linear gradient of H<sub>2</sub>O-MeCN (75:25 &#8594; 10:90 for 25&#160;min, 12 mL/min) to obtain purified compound <bold>1</bold> (7.1&#160;mg, t<sub>R</sub> 11&#160;min) and four fractions D1&#8211;D4. D2 (77.3&#160;mg) was further separated into seven subfractions (D2a&#8211;D2g) using silica gel flash chromatography and eluted with a gradient of CH<sub>2</sub>Cl<sub>2</sub>-MeOH. Compounds <bold>3</bold>&#8211;<bold>6</bold> (<bold>3</bold>, 1.7&#160;mg, t<sub>R</sub> 6.5&#160;min; <bold>4</bold>, 1.9&#160;mg, t<sub>R</sub> 7.0&#160;min; <bold>5</bold>, 0.8&#160;mg, t<sub>R</sub> 14.0&#160;min; <bold>6</bold>, 1.8&#160;mg, t<sub>R</sub> 8.0&#160;min) were purified from D2b using preparative HPLC equipped with a Spursil C<sub>18</sub>&#8211;EP column (250&#8201;&#215;&#8201;10&#160;mm, 5&#160;&#956;m, Dikma Technologies, Foothill Ranch, CA, USA) and eluted using a linear gradient of H<sub>2</sub>O-MeCN (85:15 &#8594; 60:40 for 20&#160;min, 4 mL/min). Compounds <bold>7</bold> and <bold>8</bold> (<bold>7</bold>, 1.5&#160;mg, t<sub>R</sub> 9.5&#160;min; <bold>8</bold>, 2.1&#160;mg, t<sub>R</sub> 11.0&#160;min) were isolated from D2d by preparative HPLC equipped with a Hector C<sub>18</sub> column (250&#8201;&#215;&#8201;10&#160;mm, 5&#160;&#956;m) and eluted with a linear gradient of H<sub>2</sub>O-MeCN (90:10 &#8594; 40:60 for 15&#160;min, 4 mL/min). The solvents used for preparative HPLC were purchased from J. T. Baker (Avantor, Phillipsburg, NJ, USA; #4218-03, water; 9017-03, MeCN).</p><p id="Par9">A Bruker Avance III HD 500 spectrometer (Bruker BioSpin, Billerica, MA, USA) at the Chronic and Metabolic Diseases Research Center of Sookmyung Women&#8217;s University was used for the structural identification of isolates. Pure forms of compounds <bold>3</bold>&#8211;<bold>6</bold> were unstable because isomerization occurs at room temperature<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Raw NMR data is provided as supplementary material (Figs. <xref rid="MOESM1" ref-type="media">S1</xref>&#8211;<xref rid="MOESM1" ref-type="media">S16</xref>).</p></sec><sec id="Sec5"><title>LC&#8211;MS/MS analysis</title><p id="Par10">The alkaloid-rich fraction of <italic toggle="yes">U. scandens</italic> was analyzed using a Waters Acquity UPLC system coupled with a Waters Vion IMS QTOF mass spectrometer (Waters Co., Milford, MA, USA). Chromatographic separation was performed using a mobile phase comprising 0.1% formic acid in water (A) and MeCN (B). Samples were injected into a Waters Acquity BEH C<sub>18</sub> (100&#8201;&#215;&#8201;2.1&#160;mm, 1.7&#160;&#956;m; #186002353) column with a gradient method at a flow rate of 0.3 mL/min:10&#8211;60% of B (0&#8211;20&#160;min), followed by 3&#160;min washing and 3&#160;min reconditioning. MS/MS analysis was performed in positive ion mode, and leucine enkephalin at <italic toggle="yes">m/z</italic> 556.2771 was selected as the lock mass. LC-MS grade solvents were acquired from Fisher Chemical (Thermo Fisher Scientific, Waltham, MA, USA; #W6, water; A995, MeCN).</p></sec><sec id="Sec6"><title>Cell culture</title><p id="Par11">Roswell Park Memorial Institute (RPMI; #CM058-050) or Dulbecco&#8217;s modified Eagle&#8217;s medium (DMEM; #CM001-050) (GenDepot, Katy, TX, USA) supplemented with 10% fetal bovine serum (FBS, #F0600-050, GenDepot) and 1% penicillin/streptomycin solution (#CA005-010, GenDepot) was used to maintain the human cancer cell lines H1975 (<italic toggle="yes">H. sapiens</italic> lung cancer; CVCL_1511; #CRL-5908), AGS (<italic toggle="yes">H</italic>. <italic toggle="yes">sapiens</italic> gastric cancer; CVCL_0139; #CRL-1739), and CaCo2 (<italic toggle="yes">H. sapiens</italic> colorectal cancer; CVCL_0025; #HTB-37). Cell lines were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were maintained at 37&#160;&#176;C in a humidified atmosphere containing 5% CO<sub>2</sub>. The &#945;4&#946;1 agonist (Integrin modulator 1, #HY-134130) was purchased from MedChemExpress (Monmouth Juntion, NJ, USA).</p></sec><sec id="Sec7"><title>Cell viability</title><p id="Par12">Cells (3&#8201;&#215;&#8201;10<sup>3</sup>/well) were seeded in 96-well plates, incubated overnight, and exposed to compounds at concentrations of 25, 12.5, 6.25, 3.13, and 1.56 &#181;M for 48&#160;h. MTT (#M2128, Sigma Aldrich, St. Louis, MO, USA) was added to the cultures, and cells were lysed after 4&#160;h using 150 &#181;L of DMSO (#D8418, Sigma Aldrich) at 37&#160;&#176;C. Absorbance was measured at 570&#160;nm using a microplate reader (BioTek, Winooski, VT, USA).</p></sec><sec id="Sec8"><title>Invasion assay</title><p id="Par13">Invasion assay was conducted in Transwell chambers (Corning, NY, USA) containing polycarbonate membranes with 8&#160;&#956;m pores coated with 1% gelatin. Cells were plated at 5&#8211;7&#8201;&#215;&#8201;10<sup>4</sup>/well in DMEM or RPMI containing 0.2% bovine serum albumin (BSA) in the upper compartment of the chamber with or without the tested compounds. Subsequently, the chemoattractant fibronectin was added to the lower chamber with RPMI or DMEM (600 &#181;M) containing 0.2% BSA. Following 24&#160;h of incubation, the infiltrating cells were fixed using a Diff-Quik kit (Polysciences, Inc., Warrington, PA, USA). Cells were mechanically removed from the membrane in the chamber using a cotton swab, and cells clinging to the underside of the filter were stained and counted under a light microscope<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p></sec><sec id="Sec9"><title>Scratch wound healing assay</title><p id="Par14">The scratch wound healing assay was performed using the IncuCyte system (Sartorius, G&#246;ttingen, Germany). H1975, AGS, and CaCo2 cells were seeded in Essen ImageLock 96-well plates (4&#8201;&#215;&#8201;10<sup>4</sup>/well). After an overnight incubation, a scratch wound was made on a monolayer of confluent cells using a wound marker (Sartorius). After wounding, cell debris was cleared with PBS, and the cells were incubated in DMEM or RPMI culture medium supplemented with 2% FBS, with or without the tested compounds.</p></sec><sec id="Sec10"><title>Quantitative reverse-transcription PCR</title><p id="Par15">The cells were plated at a density of 2&#8201;&#215;&#8201;10<sup>5</sup>/well on a 6-well plate and grown overnight. The cells were then treated with the compounds or DMSO. Total RNA was isolated from the cells using RNAiso Plus (#9109, TaKaRa, Otsu, Japan). The RNA (1&#160;&#181;g) was converted to cDNA using M-MLV reverse transcriptase (#28025021, Invitrogen, Carlsbad, CA, USA). qPCR was performed using SYBR Green qPCR PreMIX (#RT500, Enzynomics, Seoul, Korea). qRT-PCR was performed using a CFX instrument (Bio-Rad, Hercules, CA, USA). The list of the sequences of primers used in this study is shown in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par16">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Sequences of primers used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Gene</th><th align="left" colspan="2" rowspan="1">Primer sequences</th></tr><tr><th align="left" colspan="1" rowspan="1">Forward (5&#8242;&#8594;3&#8242;)</th><th align="left" colspan="1" rowspan="1">Reverse (5&#8242;&#8594;3&#8242;)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">E-cadherin</td><td align="left" colspan="1" rowspan="1">CAGAAAGTTTTCCACCAAAG</td><td align="left" colspan="1" rowspan="1">AAATGTGAGCAATTCTGCTT</td></tr><tr><td align="left" colspan="1" rowspan="1">N-cadherin</td><td align="left" colspan="1" rowspan="1">CTCCTATGAGTGGAACAGGAACG</td><td align="left" colspan="1" rowspan="1">TTGGATCAATGTCATAATCAAGTGCTGTA</td></tr><tr><td align="left" colspan="1" rowspan="1">SNAIL</td><td align="left" colspan="1" rowspan="1">TCCCGGGCAATTTAACAATG</td><td align="left" colspan="1" rowspan="1">TGGGAGACACATCGGTCAGA</td></tr><tr><td align="left" colspan="1" rowspan="1">TWIST</td><td align="left" colspan="1" rowspan="1">CGGGAGTCCGCA GTCTTA</td><td align="left" colspan="1" rowspan="1">TGAATCTTGCTCAGCTTGTC</td></tr><tr><td align="left" colspan="1" rowspan="1">ZEB1</td><td align="left" colspan="1" rowspan="1">ATGACA CAGGAAAGGAAGG</td><td align="left" colspan="1" rowspan="1">AGCAGTGTCTTGTTGTAG</td></tr><tr><td align="left" colspan="1" rowspan="1">ZEB2</td><td align="left" colspan="1" rowspan="1">CAAGAGGCGCAAACAAGCC</td><td align="left" colspan="1" rowspan="1">GGTTGGCAATACCGTCATCC</td></tr><tr><td align="left" colspan="1" rowspan="1">SLUG</td><td align="left" colspan="1" rowspan="1">CGAACTGGACACACATACAGTG</td><td align="left" colspan="1" rowspan="1">CTGAGGATC TCTGGTTGTGGT</td></tr><tr><td align="left" colspan="1" rowspan="1">CAV1</td><td align="left" colspan="1" rowspan="1">CTACAAGCCCAACAACAAGGC</td><td align="left" colspan="1" rowspan="1">AGGAAGCTCTTGATGCACGGT</td></tr><tr><td align="left" colspan="1" rowspan="1">WASF1</td><td align="left" colspan="1" rowspan="1">AGTTCTTCACCCAGCTCCTC</td><td align="left" colspan="1" rowspan="1">GGTGATGATGGTCGAATGCC</td></tr><tr><td align="left" colspan="1" rowspan="1">CAPN1</td><td align="left" colspan="1" rowspan="1">CCTGCTTGAGAAGGCCTATG</td><td align="left" colspan="1" rowspan="1">GGTCCACGTTGTTCCACTCT</td></tr><tr><td align="left" colspan="1" rowspan="1">WASL</td><td align="left" colspan="1" rowspan="1">GAACGAGTCCCTCTTTCACTTTC</td><td align="left" colspan="1" rowspan="1">GTTCCGATCTGCTGCATATAACT</td></tr><tr><td align="left" colspan="1" rowspan="1">RHO</td><td align="left" colspan="1" rowspan="1">AGCTCGTCTTCACCGTCAAGGA</td><td align="left" colspan="1" rowspan="1">CCAGCAGATCAGGAAAGCGATG</td></tr><tr><td align="left" colspan="1" rowspan="1">RHOA</td><td align="left" colspan="1" rowspan="1">TGCTATGTTGCCCAGACACGA</td><td align="left" colspan="1" rowspan="1">TCCACCTCGATATCTGCCAC</td></tr><tr><td align="left" colspan="1" rowspan="1">SRC</td><td align="left" colspan="1" rowspan="1">CTCATGGTGTGGTCCGTTCATC</td><td align="left" colspan="1" rowspan="1">GCTCTGCTGGCGGTTTATTCTG</td></tr><tr><td align="left" colspan="1" rowspan="1">ITGA4</td><td align="left" colspan="1" rowspan="1">GCATACAGGTGTCCAGCAGAGA</td><td align="left" colspan="1" rowspan="1">AGGACCAAGGTGGTAAGCAGCT</td></tr><tr><td align="left" colspan="1" rowspan="1">FAK</td><td align="left" colspan="1" rowspan="1">GCCTTATGACGAAATGCTGGGC</td><td align="left" colspan="1" rowspan="1">CCTGTCTTCTGGACTCCATCCT</td></tr><tr><td align="left" colspan="1" rowspan="1">&#946;-actin</td><td align="left" colspan="1" rowspan="1">ATTGTGAACTTTGGGGGATG</td><td align="left" colspan="1" rowspan="1">GATGAGATTGGCATGGCTTT</td></tr><tr><td align="left" colspan="1" rowspan="1">Vimentin</td><td align="left" colspan="1" rowspan="1">TGCCCTAAAGGAACCAATG</td><td align="left" colspan="1" rowspan="1">TCCAGCAGCTTCCTGTAGGT</td></tr><tr><td align="left" colspan="1" rowspan="1">RHOB</td><td align="left" colspan="1" rowspan="1">ACATTGAGGTGGACGGCAAGCA</td><td align="left" colspan="1" rowspan="1">CTGTCCACCGAGAAGCACATGA</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec11"><title>Western blot</title><p id="Par17">Whole cell lysates were prepared as follows: cells were plated in 6-well plates, incubated overnight, treated with DMSO or strictosamide and mitraphylline, washed twice with ice-cold PBS, and lysed with a lysis buffer. Protein concentrations in the lysates were determined using a bicinchoninic acid (BCA) assay (#23225, Thermo Fisher Scientific, Waltham, MA, USA). Antibodies against N-cadherin, FAK, and p-FAK (Tyr397) were detected with a horseradish peroxidase-conjugated secondary antibody using an Immobilon Western Chemiluminescent HRP Substrate Kit (#WBKLS, Millipore, Billerica, MA, USA) and luminescence imaging. The relative densities of the bands were obtained by normalizing the density of &#946;-actin (#4967, Cell Signaling Technology, Danvers, MA, USA) bands in each sample using Multi-Gauge 3.0 software (Fuji Photo Film Co., Ltd., Tokyo, Japan). Values are represented as arbitrary units of densitometry, corresponding to the signal intensity. The PageRuler Plus Prestained Proten Ladder (#26619, Thermo Fisher Scientific) served as a ladder. The primary and secondary antibodies used for Western blots are presented in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>. Full-length uncropped blots are provided as supplementary material (Figs. <xref rid="MOESM1" ref-type="media">S18</xref>&#8211;<xref rid="MOESM1" ref-type="media">S25</xref>).</p><p id="Par18">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Primary and secondary antibodies used in Western blotting.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Name</th><th align="left" colspan="1" rowspan="1">Species</th><th align="left" colspan="1" rowspan="1">UniProt ID</th><th align="left" colspan="1" rowspan="1">Dilution</th><th align="left" colspan="1" rowspan="1">RRID number</th><th align="left" colspan="1" rowspan="1">Catalogue number</th><th align="left" colspan="1" rowspan="1">Supplier</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">N-cadherin</td><td align="left" colspan="1" rowspan="1">Mouse</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P19022">P19022</ext-link></td><td align="left" colspan="1" rowspan="1">1:1000</td><td align="left" colspan="1" rowspan="1">AB_398236</td><td align="left" colspan="1" rowspan="1">610921</td><td align="left" colspan="1" rowspan="1">BD Bioscience</td></tr><tr><td align="left" colspan="1" rowspan="1">FAK</td><td align="left" colspan="1" rowspan="1">Mouse</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="Q05397">Q05397</ext-link></td><td align="left" colspan="1" rowspan="1">1:1000</td><td align="left" colspan="1" rowspan="1">AB_10610506</td><td align="left" colspan="1" rowspan="1">sc-271195</td><td align="left" colspan="1" rowspan="1">Santa Cruz Biotech</td></tr><tr><td align="left" colspan="1" rowspan="1">p-FAK</td><td align="left" colspan="1" rowspan="1">Mouse</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="Q05397">Q05397</ext-link></td><td align="left" colspan="1" rowspan="1">1:1000</td><td align="left" colspan="1" rowspan="1">AB_1125825</td><td align="left" colspan="1" rowspan="1">sc-81493</td><td align="left" colspan="1" rowspan="1">Santa Cruz Biotech</td></tr><tr><td align="left" colspan="1" rowspan="1">&#946;-actin</td><td align="left" colspan="1" rowspan="1">Rabbit</td><td align="left" colspan="1" rowspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="Q9UE89">Q9UE89</ext-link></td><td align="left" colspan="1" rowspan="1">1:1000</td><td align="left" colspan="1" rowspan="1">AB_330288</td><td align="left" colspan="1" rowspan="1">4967</td><td align="left" colspan="1" rowspan="1">Cell signaling</td></tr><tr><td align="left" colspan="1" rowspan="1">Goat Anti-rabbit IgG (H&#8201;+&#8201;L) Peroxidase Conjugated</td><td align="left" colspan="1" rowspan="1">Goat</td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">1:10000</td><td align="left" colspan="1" rowspan="1">AB_228341</td><td align="left" colspan="1" rowspan="1">31460</td><td align="left" colspan="1" rowspan="1">Thermo Fisher Scientific</td></tr><tr><td align="left" colspan="1" rowspan="1">Goat Anti-mouse IgG (H&#8201;+&#8201;L) Peroxidase Conjugated</td><td align="left" colspan="1" rowspan="1">Goat</td><td align="left" colspan="1" rowspan="1">N/A</td><td align="left" colspan="1" rowspan="1">1:5000</td><td align="left" colspan="1" rowspan="1">AB_228307</td><td align="left" colspan="1" rowspan="1">31430</td><td align="left" colspan="1" rowspan="1">Thermo Fisher Scientific</td></tr></tbody></table></table-wrap>
</p></sec><sec id="Sec30"><title>Real-time PCR gene array</title><p id="Par19">The Human Cell Motility RT<sup>2</sup> Profiler&#8482; PCR Array (Qiagen, SA Biosciences, Valencia, CA, USA) was used to assess the expression of motility-related genes in AGS cells that were treated with strictosamide and mitraphylline. Expression levels of 84 key genes associated with cell motility were quantified according to the manufacturer&#8217;s instructions. Fold-changes in mRNA expression were calculated based on the cycle threshold values obtained by RT-PCR. A scatter plot of the test versus control samples demonstrated the validity of the experiment. Downregulated markers were evaluated for their contribution to biological processes using Metascape (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://metascape.org">https://metascape.org</ext-link>)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p></sec><sec id="Sec13"><title>Immunofluorescence imaging</title><p id="Par20">Cancer cells were cultured on cover slips at the density of 1&#8201;&#215;&#8201;10<sup>5</sup> in a 12-well plate. After the overnight, cells were treated with DMSO or compounds for 24&#160;h. Immunofluorescence (IF) staining was performed as previously described<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, using &#945;-tubulin monoclonal antibody (B-5-1-2), Alexa Fluor&#8482; 488 (#78833, Thermo Fisher Scientific) and Alexa Fluor&#8482; 568 Phalloidin (#A12380, Thermo Fisher Scientific). K1-Fluo Confocal Laser Scanning Microscope (Nanoscope Systems, Daejeon, Republic of Korea) was used to capture the images.</p></sec><sec id="Sec14"><title>Statistical analysis</title><p id="Par21">Data are expressed as means&#8201;&#177;&#8201;standard deviation. All statistical analyses were performed using Sigma Plot 12.5 software (Systat Software Inc., Chicago, IL, USA). The statistical significance between two groups was compared using the Student&#8217;s <italic toggle="yes">t</italic>-test and <italic toggle="yes">p</italic> values&#8201;&lt;&#8201;0.05 were considered statistically significant.</p></sec></sec><sec id="Sec15"><title>Results</title><sec id="Sec12"><title>Bioactivity- and chemical profile-based isolation of monoterpene indole alkaloids from <italic toggle="yes">Uncaria scandens</italic></title><p id="Par22"><italic toggle="yes">U. scandens</italic> was selected in this study because its crude extract showed inhibitory activity in primary screening of AGS cells using an invasion assay. AGS cell line is commonly used in drug screening studies due to its well-established characteristics and reproducible responses to various treatments<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Given the known production of alkaloids in this species, an acid&#8211;base partitioning method was employed for fractionation. Among the resulting fractions, both the EtOAc and alkaloid-rich fractions exhibited the most potent activity (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A). The alkaloid-rich fraction was prioritized for further chemical investigation due to the reported abundance of alkaloids in the <italic toggle="yes">Uncaria</italic> genus. Furthermore, since liquid&#8211;liquid partitioning often distributes individual compounds across multiple fractions, it was hypothesized that alkaloids might also be present in the EtOAc fraction, potentially contributing to its observed bioactivity.</p><p id="Par23">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Bioactivity screening and chemical investigation of <italic toggle="yes">U. scandens.</italic> (<bold>A</bold>) Representative images showing each insert in the invasion assay and the relative number of invaded cells. AGS cells were treated with fractions (5&#160;&#181;g/mL; with 0.1% DMSO) for 24&#160;h. Data represent mean&#8201;&#177;&#8201;S.D. * <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; ** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01. (<bold>B</bold>) Chemical structures of the eight isolated compounds <bold>1</bold>&#8211;<bold>8</bold>. (<bold>C</bold>) The LC-MS base peak ion (BPI) chromatogram of the alkaloid-rich fraction of <italic toggle="yes">U. scandens</italic>. The isolated compounds are denoted on the corresponding chromatographic peaks. Notably, the intensities of chromatographic peaks do not represent absolute quantity of each compound because the MS signal intensity is heavily affected by ionization efficiency of each molecule.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e906" position="float" orientation="portrait" xlink:href="41598_2025_4064_Fig1_HTML.jpg"/></fig>
</p><p id="Par24">LC-MS/MS profiling of the alkaloid-rich fraction suggested the abundance of MIAs, characterized by multiple MS ion features with predicted molecular formulae containing two nitrogen atoms and falling within the m/z 350&#8211;400 range. These results also supported the presence of shared alkaloids between the alkaloid-rich and EtOAc fractions (Fig. <xref rid="MOESM1" ref-type="media">S17</xref>). Strictosamide and mitraphylline were annotated from the chemical profile by MS/MS spectral matching against the GNPS library<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>; however, many MS features remained unidentified. The alkaloid-rich fraction was subjected to chromatographic isolation and eight compounds were purified. We compared the NMR spectral data of the obtained compounds with that data available in literature and identified the isolates as strictosamide (<bold>1</bold>), mitraphylline (<bold>2</bold>), uncarine A (<bold>3</bold>), uncarine C (<bold>4</bold>), uncarine E (<bold>5</bold>), uncarine F (<bold>6</bold>), lyaloside (<bold>7</bold>), and 5(<italic toggle="yes">S</italic>)-5-carbomethoxystrictosidine (<bold>8</bold>) (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>B,C)<sup><xref ref-type="bibr" rid="CR26">26</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref></sup>. Of the eight compounds, strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) were further evaluated for their inhibitory activity against cancer cell motility as their isolated amounts were abundant and gap in literature for the investigation.</p></sec><sec id="Sec16"><title>Strictosamide and mitraphylline suppress the cell motility in human cancer cells</title><p id="Par25">We used three different cell lines in the following experimental designs, mainly because these cell lines were isolated from different types of cancers, but there are some background differences. The H1975 cell line, derived from human non-small cell lung cancer (NSCLC), carries EGFR mutations (L858R and T790M) and exhibits epithelial characteristics under basal conditions. However, H1975 cells are capable of undergoing epithelial-mesenchymal transition (EMT) upon stimulation with factors such as TGF-&#946;, contributing to enhanced migratory ability and potential resistance to EGFR-targeted therapies<sup><xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref></sup>. The AGS cell line, derived from human gastric adenocarcinoma, harbors mutations in key oncogenes and tumor suppressors, including KRAS, PIK3CA, TP53, and CTNNB1, which are frequently altered in gastric cancer and implicated in EMT regulation. While AGS cells typically exhibit an epithelial phenotype and are not highly metastatic under basal conditions, they can undergo epithelial-mesenchymal transition (EMT) upon stimulation with cytokines such as TGF-&#946;. These features make AGS a relevant and responsive model for investigating EMT-associated signaling pathways, stemness traits, and drug responses in the context of gastric cancer progression<sup><xref ref-type="bibr" rid="CR34">34</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref></sup>. On the other hand, CaCo2 cell line, derived from human colorectal adenocarcinoma, exhibits a well-differentiated epithelial phenotype and forms tight junctions and brush-border-like structures, making it a classical model for intestinal barrier and absorption studies<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. Mutations, including TP53 (a well-known tumor suppressor gene), KRAS-WT, and PIK3CA-WT, contribute to the cell line&#8217;s transformation and resistance to certain chemotherapeutic agents in CaCo2 cells<sup><xref ref-type="bibr" rid="CR43">43</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref></sup>. Strictrosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) were evaluated for their effects on the viability of H1975, AGS, and CaCo2 cells at concentrations from 1.56 to 25 &#181;M. These compounds were cytotoxic at high concentrations, but their effects were not potent (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>A). Based on these results, the concentrations for the Transwell invasion assay were determined to be 1 and 2.5 &#181;M. Strictosamide (<bold>1</bold>) inhibited the invasion of H1975, AGS, and CaCo2 cells by approximately 21, 27, and 11%, respectively, at 2.5 &#181;M after 24&#160;h, whereas mitraphylline (<bold>2</bold>) inhibited the invasion by approximately 24, 23, and 17%, respectively, under the same conditions (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B). In the wound-healing assay using the IncuCyte system, strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) decreased the number of migrating cancer cells in a dose-dependent manner (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C). In particular, mitraphylline (<bold>2</bold>) exerted a strong inhibitory effect on AGS cell migration. Our results suggested that these two compounds suppressed the motility of H1975, AGS, and CaCo2 cells.</p><p id="Par26">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>The effects of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) on cell viability and motility of H1975, AGS, and CaCo2 cells. (<bold>A</bold>) The cell viability of H1975, AGS, and CaCo2 cells treated with strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) for 48&#160;h. Data are represented as the mean&#8201;&#177;&#8201;S.D. of the differences between the cell viability of cells affected with strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) compared with that of DMSO-treated controls. (<bold>B</bold>) Representative images of each insert and relative number of invaded cells in the Transwell invasion assay. Cells were treated with strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) at concentrations of 1 and 2.5 &#181;M for 24&#160;h. (<bold>C</bold>) Representative images of each wound area and quantitative data of relative wound density in the scratch wounding migration assay using the IncuCyte system. Overlaid on phase contrast images, the green line indicates the initial wound line, while the red line indicates the migrated cell area at the specified time period. Data are represented as the mean&#8201;&#177;&#8201;S.D. *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; ** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; *** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1079" position="float" orientation="portrait" xlink:href="41598_2025_4064_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec17"><title>Strictosamide and mitraphylline regulates the markers of epithelial-mesenchymal transition</title><p id="Par27">To determine whether the motility suppression by strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) involved any regulation of EMT, the mRNA expression levels of three EMT effectors (E-cadherin, N-cadherin, and vimentin) were measured. The results showed that E-cadherin tended to be slightly upregulated, while the expression of N-cadherin mRNA was significantly downregulated by the two compounds in the three cell lines, whereas vimentin mRNA expression was not significantly downregulated in H1975 cells treated with strictosamide (<bold>1</bold>) or in CaCo2 cells treated with mitraphylline (<bold>2</bold>) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). Examination of N-cadherin protein levels supported the downregulation of N-cadherin by strictosamide and mitraphylline (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>B). The mRNA expression of the EMT transcription factors Twist, Snail, Slug, Zeb1, and Zeb2<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> were examined to determine if they were affected by strictosamide and mitraphylline. Strictosamide (<bold>1</bold>) significantly suppressed all EMT transcriptional regulators, including Twist, in H1975 cells, whereas it was more weakly modulated in CaCo2 cells than in the H1975 and AGS cell lines. In contrast, mitraphylline (<bold>2</bold>) did not significantly affect Slug and Zeb1 mRNA expression in the H1975 cell line, whereas it significantly downregulated other markers. Although mitraphylline (<bold>2</bold>) significantly downregulated all markers in the AGS cell line, the markers Slug, Zeb1, and Zeb2 exhibited a more dramatic inhibitory effect on mitraphylline (<bold>2</bold>) than on the H1975 and CaCo2 cell lines. Our results showed that both compounds decreased the expression of EMT transcription factors, suggesting that the EMT signaling pathway is related to the suppression of cancer cell motility by strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>C).</p><p id="Par28">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) downregulated the expression of EMT effectors and transcription factors. (<bold>A</bold>) The mRNA expression of EMT effectors (N-cadherin, vimentin and E-cadherin) were analyzed by qRT-PCR. The mRNA expressions were normalized against &#946;-actin. (<bold>B</bold>) The protein levels of N-cadherin were measured. &#946;-actin served as a loading control. (<bold>C</bold>) The mRNA expressions of EMT transcription factors (Twist, Snail, Slug, Zeb1, and Zeb2) were analyzed by qRT-PCR. The mRNA expressions were normalized against &#946;-actin. Data are represented as the mean&#8201;&#177;&#8201;S.D. * <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; ** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; *** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1164" position="float" orientation="portrait" xlink:href="41598_2025_4064_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec18"><title>Strictosamide and mitraphylline downregulated several cell motility-related factors and suppressing ITGA4 signaling</title><p id="Par29">To identify the mechanisms of action of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) against EMT, the mRNA expression profiles of strictosamide- and mitraphylline-treated cells were compared with those of controls using a Human Cell Motility RT<sup>2</sup> Profiler&#8482; PCR Array containing 84 cell motility-related genes. The array identified cell motility target genes, such as CAPN1, RHO, RHOA, RHOB, WASF1, WASL, CAV1, EGF, SRC, and ITGA4. Among them, ITGA4 was the most downregulated by strictosamide (<bold>1</bold>) (&#8722; 17.42, fold change) and mitraphylline (<bold>2</bold>) (&#8722; 11.42, fold change) (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>A). Based on the PCR array results, downregulated genes were screened for potential associations using the Search Tool for the Retrieval of Interacting Genes (STRING) database<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. A protein-protein association network comprising CAV1, CAPN1, ITGA4, PTK2, RHO, RHOA, RHOB, SRC, WASF1, and WASL was acquired (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>B). The RT-PCR gene array results were further validated by quantifying the relative mRNA expression of genes listed in the protein network. Focal adhesion kinase (FAK) was also examined because it is associated with integrin signaling<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. Strictosamide (<bold>1</bold>) downregulated all genes (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C), confirming the PCR array profiling, and significantly downregulated ITGA4, FAK, and SRC mRNA expression in all the cell lines. However, mitraphylline (<bold>2</bold>) had different effects on these cell lines. RT<sup>2</sup> PCR array analysis confirmed the downregulation of ITGA4, SRC, RHOB, WASF1, and CAV1 in AGS cells. Mitraphylline (<bold>2</bold>) significantly downregulated RHO, RHOA, and ITGA4 in H1975 cells but did not significantly alter the expression of other regulators. The expression of ITGA4, FAK, and SRC was not downregulated in CaCo2 cells after mitraphylline (<bold>2</bold>) treatment, whereas the expression of CAPN1, WASL1, and RHOB was significantly downregulated. This result suggests that mitraphylline (<bold>2</bold>) has different mechanical effects on CaCo2 cell line. These results suggested that strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) inhibited cancer cell motility via ITGA4 signaling (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C).</p><p id="Par30">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) downregulated several cell motility-related factors. (<bold>A</bold>) Pathway-focused gene expression analysis using the Human Cell Motility RT<sup>2</sup> Profiler&#8482; PCR Array was performed to examine the mechanisms by which strictosamide and mitraphylline modulate cell motility. The scatter plot compares the gene on the PCR Array between the DMSO-strictosamide and DMSO-mitraphylline. The number of fold changes for ITGA4 arranged downwards is shown in the figure. (<bold>B</bold>) A network of interrelated genes affected by strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>). (<bold>C</bold>) Quantitative analysis of the mRNA expressions of CAV1, CAPN1, WASF1, WASL, RHO, RHOA, RHOB, ITGA4, FAK, SRC in H1975, AGS, and CaCo2 cells treated with 2.5 &#181;M of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>). Data are represented as the mean&#8201;&#177;&#8201;S.D. * <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; ** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; *** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1282" position="float" orientation="portrait" xlink:href="41598_2025_4064_Fig4_HTML.jpg"/></fig>
</p></sec><sec id="Sec19"><title>Effect of strictosamide and mitraphylline on cell morphology and reorganization of the actin cytoskeleton</title><p id="Par31">We further analyzed the effect of downregulated markers on biological processes in Metascape. The results showed that the effect of the alkaloids is associated with regulating actin cytoskeleton regulation and regulate cell adhesion (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>A). Cell motility is linked to EMT, loss of the cell-cell adhesion protein E-cadherin, rupture of cell-cell junctions, and actin cytoskeleton reorganization<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Therefore, tubulin and F-actin staining were performed to examine the distribution of cell morphology and cytoskeletal components in strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) treatment compared to control. The results reveal that the cell-cell adhesion of the treated cells was tighter and mesenchymal cell morphology was less observed compared to the control group (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>B). Interactions between the extracellular matrix, regulation of the actin cytoskeleton, mesenchymal cell adhesion, and cell motility are regulated through focal adhesions. High expression of FAK is related to the EMT process and increased cell migration<sup><xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR52">52</xref></sup>. For a further validation, we checked total-FAK and phosphorylated-FAK (Tyr397) protein levels to investigate the effect of the alkaloids against EMT and ITGA4-associated FAK activation. The result revealed that the level of phosphor-FAK (Tyr 397) and/or the level of total FAK were decreased compared to the control group (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>C).</p><p id="Par32">
<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Effect of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) on cell morphology and FAK protein level of cancer cells. (<bold>A</bold>) Biological processes linked to the pathways by strictosamide (<bold>1</bold>) and mitraphylline (<bold>2)</bold> found in Metascape. (<bold>B</bold>) The microtubule organization in the H1975, CaCo2, and AGS cells was examined using immunofluorescence microscopy following a 24&#160;h treatment with strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>). Microtubules were stained with &#945;-tubulin antibodies (green), while actin was stained with Alexa Fluor 568 phalloidin (red). (<bold>C</bold>) The protein levels of p-FAK and total FAK were measured. Cells were treated with 1 and 2.5 &#181;M of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) for 48&#160;h. &#946;-actin served as a loading control. Data are represented as the mean&#8201;&#177;&#8201;S.D. * <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05; ** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01; *** <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1368" position="float" orientation="portrait" xlink:href="41598_2025_4064_Fig5_HTML.jpg"/></fig>
</p></sec><sec id="Sec20"><title>The responses against strictosamide and mitraphylline in cells exposed to &#913;4&#946;1 agonist</title><p id="Par33">We checked the responses against strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) in cells treated with an &#945;4&#946;1 agonist molecule developed by Baiula and co-authors<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>A). We first performed a cell viability assay to determine the appropriate concentration and used the &#945;4&#946;1 agonist at concentrations of 2.5 &#181;M in qRT-PCR and Transwell invasion assays (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>B).</p><p id="Par34">
<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>The responses to strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) were evaluated in cells exposed &#945;4&#946;1 agonist. (<bold>A</bold>) Chemical structure of the &#945;4&#946;1 agonist molecule. (<bold>B</bold>) Cell viability in ITGA4 agonist treated in AGS cells. Cells were treated with &#945;4&#946;1 agonist for 48&#160;h with indicated concentration. (<bold>C</bold>) Relative mRNA levels of N-cadherin, ITGA4 and FAK, after treatment with strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) for 48&#160;h in AGS cells. (<bold>D</bold>) Representative images of each insert and relative number of invaded cells in the Transwell invasion assay. AGS cells were treated with strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) at concentrations of 1 and 2.5 &#181;M for 24&#160;h. The &#945;4&#946;1 agonist was treated at a concentration of 2.5 &#181;M. Data are presented as mean&#8201;&#177;&#8201;S.D. Statistical significance was determined as follows: *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, NS: not significant (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05) compared to DMSO-treated cells; #<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, ##<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, ###<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, NS: not significant (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05) compared to &#945;4&#946;1 agonist-treated cells; @<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05, @@<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, @@@<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001, NS: not significant (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05) compared to strictosamide <bold>(1)</bold>- or mitraphylline <bold>(2)</bold>-treated cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1475" position="float" orientation="portrait" xlink:href="41598_2025_4064_Fig6_HTML.jpg"/></fig>
</p><p id="Par35">In &#945;4&#946;1 agonist treated cells, the mRNA levels of N-cadherin, ITGA4 and FAK were upregulated. However, in groups of cells co-treated with the &#945;4&#946;1 agonist and the alkaloids, N-cadherin and ITGA4 levels retained their capacity to be downregulated by strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>), whereas FAK levels were not significantly downregulated (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>C). We then checked these results with a phenotypic assay. The results were consistent in that the number of invaded cells induced by the &#945;4&#946;1 agonist treatment was reduced when co-treated with the alkaloids (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>D). Overall, treatment of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) continued to significantly suppress cell motility, although the response was attenuated in the cells treated with the ITGA4 agonist. Comparing between strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>), mitraphylline (<bold>2</bold>) exhibited a stronger inhibitory effect in &#945;4&#946;1 agonist-treated cells.</p></sec></sec><sec id="Sec21"><title>Discussion</title><p id="Par36">Integrins provide outside-in signals that control cell destiny and mediate physical adhesion to appropriate matrices/ligands<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Among the integrin family, ITGA4 is crucial for cell survival, proliferation, migration, invasion, and tumor growth and spread, and high ITGA4 expression is associated with metastasis in many cancer types<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. It has several ligands including fibronectin, osteopontin, fibrillin, thrombospondin, ADAM, COMP, and L1<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Fibronectin is an important mesenchymal ECM glycoprotein involved in cell motility, matrix adherence, and cell-to-cell contact<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Furthermore, integrin clustering activates focal adhesion kinase (FAK) to cause tyrosine phosphorylation<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. The focal adhesion complex is composed of the structural proteins vinculin, paxillin, and talin, along with SRC and FAK<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Several signaling pathways are controlled by FAK activation, which also causes EMT in different cancer cells<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. The activation of the SRC/FAK pathway in cancer cells can result in several forms of invasion, which require different Rho GTPases<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Rho, RhoA, and RhoB family GTPases are important regulators of cell adhesion, cytoskeleton, and cell migration. RhoA activation promotes the production of actin stress fibers and protein clusters associated with focal adhesions<sup><xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. RHOA upregulation promotes angiogenesis and cell migration<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. The results of the present study indicated that strictosamide and mitraphylline affect cell motility by decreasing the expression of ITGA4-related genes (FAK, SRC, and RhoA) and EMT markers (N-cadherin, Vimentin, Twist, Snail, Slug, Zeb1, and Zeb2).</p><p id="Par37">EMT is also intricately linked to the acquisition of cancer stem cell (CSC)-like properties and the development of resistance to anticancer therapies<sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup>. Cells undergoing EMT often exhibit stemness markers and features such as self-renewal and tumor-initiating capacity, which contribute to tumor heterogeneity and recurrence. Furthermore, EMT-driven changes in gene expression can promote survival pathways and reduce drug uptake or increase drug efflux, collectively leading to chemoresistance<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup>. Promoting migratory and invasive properties, epithelial-to-mesenchymal transition (EMT) is functionally and mechanistically linked to the acquisition of cancer stem cell (CSC) characteristics. EMT markers such as Snail, Slug, Twist, and <italic toggle="yes">Zeb1</italic> have been directly implicated in the induction of stemness in epithelial cancer cells<sup><xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR67">67</xref>&#8211;<xref ref-type="bibr" rid="CR69">69</xref>,</sup>. Therefore, the modulation of EMT by the investigated compounds in our study may have broader implications beyond cell motility, potentially influencing CSC-related traits and therapeutic resistance.</p><p id="Par38">Strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) downregulate the expression of other cell motility factors in combination with ITGA4/FAK/SRC/RHOs axis or independently. CAPN1 induces membrane detachment rate associated with peripheral focal adhesions, resulting in cell motility<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. While Cav1 is associated with metastasis, it is also involved in cancer-related processes, such as tumor growth and drug resistance<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Cav1 phosphorylation promotes cell motility by promoting the association of stabilized FAK with focal adhesions through the RHO/ROCK signaling cascade<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. In contrast, Wiskott-Aldrich syndrome proteins (WASPs) are involved in cellular processes through the transmission of GTPase activation signals<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. WASF1/2/3 and WASL proteins promote the Arp2/3 (actin-related protein 2/3) complex in response to extracellular signaling, resulting in actin fiber recruitment and induction of actin polymerization<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Previous studies showed that WASF1 and WASL promote cancer cell motility<sup><xref ref-type="bibr" rid="CR75">75</xref>,<xref ref-type="bibr" rid="CR76">76</xref></sup>. With these knowledges, the results of the present study suggest that strictosamide and mitraphylline regulate multiple signaling pathways.&#160;Even through the pharmacological aspects of investigation of strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) have been broadly studied, the present study is the first report&#8212; to the best of our knowledge&#8212;to highlight the cell motility-suppressive effects of the compounds. Strictosamide (<bold>1</bold>) has been previously reported to exhibit anti-inflammatory<sup><xref ref-type="bibr" rid="CR77">77</xref>,<xref ref-type="bibr" rid="CR78">78</xref></sup> and anthelmintic<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> activities, whereas mitraphylline (<bold>2</bold>) has shown anti-inflammatory<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> and immunomodulatory<sup><xref ref-type="bibr" rid="CR81">81</xref></sup> activities. Notably, strictosamide (<bold>1</bold>) and mitraphylline (<bold>2</bold>) possess different skeleton types, although they are classified as MIAs. Strictosamide (<bold>1</bold>) is classified as having a rigid vallesiachotaman-type skeleton, whereas mitraphylline (<bold>2</bold>) is a spirocyclic oxindole alkaloid specifically distributed in the genus <italic toggle="yes">Uncaria</italic><sup><xref ref-type="bibr" rid="CR82">82</xref>,<xref ref-type="bibr" rid="CR83">83</xref></sup>. However, future studies should comprehensively investigate the morphological changes of these alkaloids on actin and other cytoskeletal components that play a role in EMT processes and mechanical effects on the ITGA4/FAK axis. Differences in cellular processes because of different factors such as ITGA4 expression differences in cell lines and ECM substrates may cause differences in sensitivity and response to these alkaloids. Therefore, experimental designs such as ITGA4 overexpression and knockdown cell modeling or response tests with ITGA4 small molecule inhibitors can guide future studies. Another noteworthy point is that, mitraphylline <bold>(2)</bold> modulated EMT-related gene expression in a cell-type-specific manner. While ITGA4, FAK, and SRC were significantly downregulated in AGS and H1975 cells, CaCo2 cells showed limited changes in these targets, with downregulation observed instead in CAPN1, WASL1, and RHOB. This difference likely reflects the epithelial phenotype and lower EMT plasticity of CaCo2 cells, along with potential variations in basal signaling, mutational profile, or compound bioavailability<sup><xref ref-type="bibr" rid="CR84">84</xref>,<xref ref-type="bibr" rid="CR85">85</xref></sup>. These findings underscore the importance of cellular context in interpreting EMT modulation by natural compounds. Further investigations can help expand the potential of these two compounds and their analogs as anti-metastatic agents in different types of cancer therapy.</p><p id="Par39">It should be noted that mitraphylline (<bold>2)</bold> undergoes spontaneous isomerization to isomitraphylline, a 7-epimer given via retro-Mannich interconversion of the spiro structure<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>. It was reported that the isomerization of mitraphylline (<bold>2)</bold> occurs in normal cell culture condition<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Thus, the biological activity shown in this study should be considered as a result from a mixture of mitraphylline (<bold>2)</bold> and isomitraphylline. This needs to be considered for further investigations performed in a molecular level.</p></sec><sec id="Sec22" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2025_4064_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>M&#252;cahit Varl&#305; and Kyungha Lee contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Dr. Mehdi Beniddir (Universit&#233; Paris-Saclay, France) and Dr. Pierre Le Pogam (Universit&#233; Paris-Saclay, France) for constructive discussion on the distribution of monoterpene indole alkaloids in the family Rubiaceae.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>M&#252;cahit Varl&#305;: Data Curation, Investigation, Methodology, Visualization, Writing &#8211; original draft. Kyungha Lee: Data Curation, Investigation, Writing &#8211; original draft. Tran The Bach: Investigation, Resources, Writing &#8211; review &amp; editing. Tran Duc Binh: Investigation, Resources, Writing &#8211; review &amp; editing. Hangun Kim: Conceptualization, Project administration, Supervision, Writing &#8211; review &amp; editing. Kyo Bin Kang: Conceptualization, Project administration, Supervision, Writing &#8211; review &amp; editing.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the National Research Foundation of Korea Grants (NRF-2021K1A3A1A21038059, 2022R1A5A2021216, and RS-2024-00413760) funded by the Korean government (MSIT), the KRIBB Initiative Program of Korea, and project &#272;T&#272;L.CN-72/22 in Vietnam.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in this published article and its supplementary information files.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par40">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganesh</surname><given-names>K</given-names></name><name name-style="western"><surname>Massagu&#233;</surname><given-names>J</given-names></name></person-group><article-title>Targeting metastatic cancer</article-title><source>Nat. Med.</source><year>2021</year><volume>27</volume><fpage>34</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-01195-4</pub-id><pub-id pub-id-type="pmid">33442008</pub-id><pub-id pub-id-type="pmcid">PMC7895475</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Ganesh, K. &amp; Massagu&#233;, J. Targeting metastatic cancer. <italic toggle="yes">Nat. Med.</italic><bold>27</bold>, 34&#8211;44 (2021).<pub-id pub-id-type="pmid">33442008</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-020-01195-4</pub-id><pub-id pub-id-type="pmcid">PMC7895475</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mittal</surname><given-names>V</given-names></name></person-group><article-title>Epithelial mesenchymal transition in aggressive lung cancers</article-title><source>Adv. Exp. Med. Biol.</source><year>2016</year><volume>890</volume><fpage>37</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-24932-2_3</pub-id><pub-id pub-id-type="pmid">26703798</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Mittal, V. Epithelial mesenchymal transition in aggressive lung cancers. <italic toggle="yes">Adv. Exp. Med. Biol.</italic><bold>890</bold>, 37&#8211;56 (2016).<pub-id pub-id-type="pmid">26703798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-319-24932-2_3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Said</surname><given-names>NABM</given-names></name><name name-style="western"><surname>Williams</surname><given-names>ED</given-names></name></person-group><article-title>Growth factors in induction of epithelial-mesenchymal transition and metastasis</article-title><source>Cells Tissues Organs.</source><year>2011</year><volume>193</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1159/000320360</pub-id><pub-id pub-id-type="pmid">21051862</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Said, N. A. B. M. &amp; Williams, E. D. Growth factors in induction of epithelial-mesenchymal transition and metastasis. <italic toggle="yes">Cells Tissues Organs.</italic><bold>193</bold>, 85&#8211;97 (2011).<pub-id pub-id-type="pmid">21051862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000320360</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamouille</surname><given-names>S</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Derynck</surname><given-names>R</given-names></name></person-group><article-title>Molecular mechanisms of epithelial-mesenchymal transition</article-title><source>Nat. Rev. Mol. Cell. Biol.</source><year>2014</year><volume>15</volume><fpage>178</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/nrm3758</pub-id><pub-id pub-id-type="pmid">24556840</pub-id><pub-id pub-id-type="pmcid">PMC4240281</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Lamouille, S., Xu, J. &amp; Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. <italic toggle="yes">Nat. Rev. Mol. Cell. Biol.</italic><bold>15</bold>, 178&#8211;196 (2014).<pub-id pub-id-type="pmid">24556840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm3758</pub-id><pub-id pub-id-type="pmcid">PMC4240281</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santamaria</surname><given-names>PG</given-names></name><name name-style="western"><surname>Moreno-Bueno</surname><given-names>G</given-names></name><name name-style="western"><surname>Portillo</surname><given-names>F</given-names></name><name name-style="western"><surname>Cano</surname><given-names>A</given-names></name></person-group><article-title>EMT: Present and future in clinical oncology</article-title><source>Mol. Oncol.</source><year>2017</year><volume>11</volume><fpage>718</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1002/1878-0261.12091</pub-id><pub-id pub-id-type="pmid">28590039</pub-id><pub-id pub-id-type="pmcid">PMC5496494</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Santamaria, P. G., Moreno-Bueno, G., Portillo, F. &amp; Cano, A. EMT: Present and future in clinical oncology. <italic toggle="yes">Mol. Oncol.</italic><bold>11</bold>, 718&#8211;738 (2017).<pub-id pub-id-type="pmid">28590039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1878-0261.12091</pub-id><pub-id pub-id-type="pmcid">PMC5496494</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ribatti</surname><given-names>D</given-names></name><name name-style="western"><surname>Tamma</surname><given-names>R</given-names></name><name name-style="western"><surname>Annese</surname><given-names>T</given-names></name></person-group><article-title>Epithelial-mesenchymal transition in cancer: A historical overview</article-title><source>Transl. Oncol.</source><year>2020</year><volume>13</volume><fpage>100773</fpage><pub-id pub-id-type="doi">10.1016/j.tranon.2020.100773</pub-id><pub-id pub-id-type="pmid">32334405</pub-id><pub-id pub-id-type="pmcid">PMC7182759</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Ribatti, D., Tamma, R. &amp; Annese, T. Epithelial-mesenchymal transition in cancer: A historical overview. <italic toggle="yes">Transl. Oncol.</italic><bold>13</bold>, 100773 (2020).<pub-id pub-id-type="pmid">32334405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tranon.2020.100773</pub-id><pub-id pub-id-type="pmcid">PMC7182759</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hong</surname><given-names>W</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name></person-group><article-title>The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis</article-title><source>J. Hematol. Oncol.</source><year>2022</year><volume>15</volume><fpage>129</fpage><pub-id pub-id-type="doi">10.1186/s13045-022-01347-8</pub-id><pub-id pub-id-type="pmid">36076302</pub-id><pub-id pub-id-type="pmcid">PMC9461252</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Huang, Y., Hong, W. &amp; Wei, X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. <italic toggle="yes">J. Hematol. Oncol.</italic><bold>15</bold>, 129 (2022).<pub-id pub-id-type="pmid">36076302</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13045-022-01347-8</pub-id><pub-id pub-id-type="pmcid">PMC9461252</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Mustafa</surname><given-names>NR</given-names></name><name name-style="western"><surname>Tang</surname><given-names>K</given-names></name><name name-style="western"><surname>Choi</surname><given-names>YH</given-names></name><name name-style="western"><surname>Verpoorte</surname><given-names>R</given-names></name></person-group><article-title>Monoterpenoid Indole alkaloids biosynthesis and its regulation in <italic toggle="yes">Catharanthus roseus</italic>: A literature review from genes to metabolites</article-title><source>Phytochem. Rev.</source><year>2016</year><volume>15</volume><fpage>221</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1007/s11101-015-9406-4</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Pan, Q., Mustafa, N. R., Tang, K., Choi, Y. H. &amp; Verpoorte, R. Monoterpenoid Indole alkaloids biosynthesis and its regulation in <italic toggle="yes">Catharanthus roseus</italic>: A literature review from genes to metabolites. <italic toggle="yes">Phytochem. Rev.</italic><bold>15</bold>, 221&#8211;250 (2016).</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Connor</surname><given-names>SE</given-names></name><name name-style="western"><surname>Maresh</surname><given-names>JJ</given-names></name></person-group><article-title>Chemistry and biology of monoterpene Indole alkaloid biosynthesis</article-title><source>Nat. Prod. Rep.</source><year>2006</year><volume>23</volume><fpage>532</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1039/b512615k</pub-id><pub-id pub-id-type="pmid">16874388</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">O&#8217;Connor, S. E. &amp; Maresh, J. J. Chemistry and biology of monoterpene Indole alkaloid biosynthesis. <italic toggle="yes">Nat. Prod. Rep.</italic><bold>23</bold>, 532&#8211;547 (2006).<pub-id pub-id-type="pmid">16874388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/b512615k</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>R</given-names></name><etal/></person-group><article-title>The lichen secondary metabolite Atranorin suppresses lung cancer cell motility and tumorigenesis</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>8136</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-08225-1</pub-id><pub-id pub-id-type="pmid">28811522</pub-id><pub-id pub-id-type="pmcid">PMC5557893</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Zhou, R. et al. The lichen secondary metabolite Atranorin suppresses lung cancer cell motility and tumorigenesis. <italic toggle="yes">Sci. Rep.</italic><bold>7</bold>, 8136 (2017).<pub-id pub-id-type="pmid">28811522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-08225-1</pub-id><pub-id pub-id-type="pmcid">PMC5557893</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Marine depsipeptide nobilamide I inhibits cancer cell motility and tumorigenicity via suppressing epithelial-mesenchymal transition and MMP2/9 expression</article-title><source>ACS Omega</source><year>2022</year><volume>7</volume><fpage>1722</fpage><lpage>1732</lpage><pub-id pub-id-type="doi">10.1021/acsomega.1c04520</pub-id><pub-id pub-id-type="pmid">35071867</pub-id><pub-id pub-id-type="pmcid">PMC8771697</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Le, T. C. et al. Marine depsipeptide nobilamide I inhibits cancer cell motility and tumorigenicity via suppressing epithelial-mesenchymal transition and MMP2/9 expression. <italic toggle="yes">ACS Omega</italic>. <bold>7</bold>, 1722&#8211;1732 (2022).<pub-id pub-id-type="pmid">35071867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsomega.1c04520</pub-id><pub-id pub-id-type="pmcid">PMC8771697</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulat</surname><given-names>S</given-names></name><etal/></person-group><article-title>Marinobazzanan, a bazzanane-type sesquiterpenoid, suppresses the cell motility and tumorigenesis in cancer cells</article-title><source>Mar. Drugs</source><year>2023</year><volume>21</volume><fpage>153</fpage><pub-id pub-id-type="doi">10.3390/md21030153</pub-id><pub-id pub-id-type="pmid">36976200</pub-id><pub-id pub-id-type="pmcid">PMC10056982</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Pulat, S. et al. Marinobazzanan, a bazzanane-type sesquiterpenoid, suppresses the cell motility and tumorigenesis in cancer cells. <italic toggle="yes">Mar. Drugs</italic>. <bold>21</bold>, 153 (2023).<pub-id pub-id-type="pmid">36976200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/md21030153</pub-id><pub-id pub-id-type="pmcid">PMC10056982</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>N</given-names></name><etal/></person-group><article-title>Recent research progress of <italic toggle="yes">Uncaria</italic> spp. based on alkaloids: Phytochemistry, Pharmacology and structural chemistry</article-title><source>Eur. J. Med. Chem.</source><year>2021</year><volume>210</volume><fpage>112960</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112960</pub-id><pub-id pub-id-type="pmid">33148492</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Qin, N. et al. Recent research progress of <italic toggle="yes">Uncaria</italic> spp. based on alkaloids: Phytochemistry, Pharmacology and structural chemistry. <italic toggle="yes">Eur. J. Med. Chem.</italic><bold>210</bold>, 112960 (2021).<pub-id pub-id-type="pmid">33148492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2020.112960</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaiser</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cat-s claw oxindole alkaloid isomerization induced by cell incubation and cytotoxic activity against T24 and RT4 human bladder Cancer cell lines</article-title><source>Planta Med.</source><year>2013</year><volume>79</volume><fpage>1413</fpage><lpage>1420</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1350742</pub-id><pub-id pub-id-type="pmid">23975868</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Kaiser, S. et al. Cat-s claw oxindole alkaloid isomerization induced by cell incubation and cytotoxic activity against T24 and RT4 human bladder Cancer cell lines. <italic toggle="yes">Planta Med.</italic><bold>79</bold>, 1413&#8211;1420 (2013).<pub-id pub-id-type="pmid">23975868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0033-1350742</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ndagijimana</surname><given-names>A</given-names></name><etal/></person-group><article-title>A review on Indole alkaloids isolated from <italic toggle="yes">Uncaria rhynchophylla</italic> and their Pharmacological studies</article-title><source>Fitoterapia</source><year>2013</year><volume>86</volume><fpage>35</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.01.018</pub-id><pub-id pub-id-type="pmid">23376412</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ndagijimana, A. et al. A review on Indole alkaloids isolated from <italic toggle="yes">Uncaria rhynchophylla</italic> and their Pharmacological studies. <italic toggle="yes">Fitoterapia</italic><bold>86</bold>, 35&#8211;47 (2013).<pub-id pub-id-type="pmid">23376412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fitote.2013.01.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azevedo</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Antioxidant activity of an aqueous leaf extract from <italic toggle="yes">Uncaria tomentosa</italic> and its major alkaloids mitraphylline and Isomitraphylline in Caenorhabditis elegans</article-title><source>Molecules</source><year>2019</year><volume>24</volume><fpage>3299</fpage><pub-id pub-id-type="doi">10.3390/molecules24183299</pub-id><pub-id pub-id-type="pmid">31510078</pub-id><pub-id pub-id-type="pmcid">PMC6766911</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Azevedo, B. C. et al. Antioxidant activity of an aqueous leaf extract from <italic toggle="yes">Uncaria tomentosa</italic> and its major alkaloids Mitraphylline and Isomitraphylline in Caenorhabditis elegans. <italic toggle="yes">Molecules</italic><bold>24</bold>, 3299 (2019).<pub-id pub-id-type="pmid">31510078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules24183299</pub-id><pub-id pub-id-type="pmcid">PMC6766911</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Monoterpene Indole alkaloids in <italic toggle="yes">Uncaria rhynchophlly</italic> (Miq.) jacks chinensis and their chemotaxonomic significance</article-title><source>Biochem. Syst. Ecol.</source><year>2020</year><volume>91</volume><fpage>104057</fpage><pub-id pub-id-type="doi">10.1016/j.bse.2020.104057</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Chen, Z. et al. Monoterpene Indole alkaloids in <italic toggle="yes">Uncaria rhynchophlly</italic> (Miq.) jacks chinensis and their chemotaxonomic significance. <italic toggle="yes">Biochem. Syst. Ecol.</italic><bold>91</bold>, 104057 (2020).</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chemical constituents of <italic toggle="yes">Uncaria scandens</italic></article-title><source>Chem. Nat. Compd.</source><year>2018</year><volume>54</volume><fpage>793</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1007/s10600-018-2478-9</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Yang, A. et al. Chemical constituents of <italic toggle="yes">Uncaria scandens</italic>. <italic toggle="yes">Chem. Nat. Compd</italic>. <bold>54</bold>, 793&#8211;794 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JG</given-names></name><name name-style="western"><surname>Huang</surname><given-names>XY</given-names></name><name name-style="western"><surname>Ma</surname><given-names>YB</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Geng</surname><given-names>CA</given-names></name></person-group><article-title>UFLC-PDA-MS/MS profiling of seven <italic toggle="yes">Uncaria</italic> species integrated with Melatonin/5-Hydroxytryptamine receptors agonistic assay</article-title><source>Nat. Prod. Bioprospect.</source><year>2020</year><volume>10</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s13659-020-00230-8</pub-id><pub-id pub-id-type="pmid">31933166</pub-id><pub-id pub-id-type="pmcid">PMC7046893</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Zhang, J. G., Huang, X. Y., Ma, Y. B., Chen, J. J. &amp; Geng, C. A. UFLC-PDA-MS/MS profiling of seven <italic toggle="yes">Uncaria</italic> species integrated with Melatonin/5-Hydroxytryptamine receptors agonistic assay. <italic toggle="yes">Nat. Prod. Bioprospect.</italic><bold>10</bold>, 23&#8211;36 (2020).<pub-id pub-id-type="pmid">31933166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13659-020-00230-8</pub-id><pub-id pub-id-type="pmcid">PMC7046893</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bairoch</surname><given-names>A</given-names></name></person-group><article-title>The Cellosaurus, a cell-line knowledge resource</article-title><source>J. Biomol. Tech.</source><year>2018</year><volume>29</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.7171/jbt.18-2902-002</pub-id><pub-id pub-id-type="pmid">29805321</pub-id><pub-id pub-id-type="pmcid">PMC5945021</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Bairoch, A. The Cellosaurus, a cell-line knowledge resource. <italic toggle="yes">J. Biomol. Tech.</italic><bold>29</bold>, 25&#8211;38 (2018).<pub-id pub-id-type="pmid">29805321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7171/jbt.18-2902-002</pub-id><pub-id pub-id-type="pmcid">PMC5945021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>1523</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id><pub-id pub-id-type="pmid">30944313</pub-id><pub-id pub-id-type="pmcid">PMC6447622</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. <italic toggle="yes">Nat. Commun.</italic><bold>10</bold>, 1523 (2019).<pub-id pub-id-type="pmid">30944313</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-09234-6</pub-id><pub-id pub-id-type="pmcid">PMC6447622</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gamage</surname><given-names>CDB</given-names></name><etal/></person-group><article-title>Libertellenone T, a novel compound isolated from Endolichenic fungus, induces G2/M phase arrest, apoptosis, and autophagy by activating the ROS/JNK pathway in colorectal cancer cells</article-title><source>Cancers</source><year>2023</year><volume>15</volume><fpage>489</fpage><pub-id pub-id-type="doi">10.3390/cancers15020489</pub-id><pub-id pub-id-type="pmid">36672439</pub-id><pub-id pub-id-type="pmcid">PMC9857212</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Gamage, C. D. B. et al. Libertellenone T, a novel compound isolated from Endolichenic fungus, induces G2/M phase arrest, apoptosis, and autophagy by activating the ROS/JNK pathway in colorectal cancer cells. <italic toggle="yes">Cancers</italic>. <bold>15</bold>, 489 (2023).<pub-id pub-id-type="pmid">36672439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers15020489</pub-id><pub-id pub-id-type="pmcid">PMC9857212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flobak</surname><given-names>&#197;</given-names></name><etal/></person-group><article-title>A high-throughput drug combination screen of targeted small molecule inhibitors in cancer cell lines</article-title><source>Sci. Data</source><year>2019</year><volume>6</volume><fpage>237</fpage><pub-id pub-id-type="doi">10.1038/s41597-019-0255-7</pub-id><pub-id pub-id-type="pmid">31664030</pub-id><pub-id pub-id-type="pmcid">PMC6820772</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Flobak, &#197;. et al. A high-throughput drug combination screen of targeted small molecule inhibitors in cancer cell lines. <italic toggle="yes">Sci. Data</italic><bold>6</bold>, 237 (2019).<pub-id pub-id-type="pmid">31664030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41597-019-0255-7</pub-id><pub-id pub-id-type="pmcid">PMC6820772</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendiola</surname><given-names>M</given-names></name><etal/></person-group><article-title>Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma</article-title><source>Biomed. Pharmacother.</source><year>2024</year><volume>173</volume><fpage>116397</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2024.116397</pub-id><pub-id pub-id-type="pmid">38479181</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Mendiola, M. et al. Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma. <italic toggle="yes">Biomed. Pharmacother.</italic><bold>173</bold>, 116397 (2024).<pub-id pub-id-type="pmid">38479181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2024.116397</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sharing and community curation of mass spectrometry data with global natural products social molecular networking</article-title><source>Nat. Biotechnol.</source><year>2016</year><volume>34</volume><fpage>828</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1038/nbt.3597</pub-id><pub-id pub-id-type="pmid">27504778</pub-id><pub-id pub-id-type="pmcid">PMC5321674</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Wang, M. et al. Sharing and community curation of mass spectrometry data with global natural products social molecular networking. <italic toggle="yes">Nat. Biotechnol.</italic><bold>34</bold>, 828&#8211;837 (2016).<pub-id pub-id-type="pmid">27504778</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.3597</pub-id><pub-id pub-id-type="pmcid">PMC5321674</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>F</given-names></name><name name-style="western"><surname>Messana</surname><given-names>I</given-names></name><name name-style="western"><surname>Botta</surname><given-names>B</given-names></name><name name-style="western"><surname>de Mello</surname><given-names>JF</given-names></name></person-group><article-title>Constituents of Guettarda platypoda</article-title><source>J. Nat. Prod.</source><year>1986</year><volume>49</volume><fpage>1150</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1021/np50048a041</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Ferrari, F., Messana, I., Botta, B. &amp; de Mello, J. F. Constituents of Guettarda platypoda. <italic toggle="yes">J. Nat. Prod.</italic><bold>49</bold>, 1150&#8211;1151 (1986).</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seki</surname><given-names>H</given-names></name><name name-style="western"><surname>Takayama</surname><given-names>H</given-names></name><name name-style="western"><surname>Aimi</surname><given-names>N</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>S-I</given-names></name><name name-style="western"><surname>Ponglux</surname><given-names>D</given-names></name></person-group><article-title>A nuclear magnetic resonance study on the eleven stereoisomers of Heteroyohimbine-type oxindole alkaloids</article-title><source>Chem. Pharm. Bull.</source><year>1993</year><volume>41</volume><fpage>2077</fpage><lpage>2086</lpage><pub-id pub-id-type="doi">10.1248/cpb.41.2077</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Seki, H., Takayama, H., Aimi, N., Sakai, S-I. &amp; Ponglux, D. A nuclear magnetic resonance study on the eleven stereoisomers of Heteroyohimbine-Type oxindole alkaloids. <italic toggle="yes">Chem. Pharm. Bull.</italic><bold>41</bold>, 2077&#8211;2086 (1993).</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aimi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Isolation of alkaloids from cultured hybrid cells of <italic toggle="yes">Rauwolfia serpentina</italic> &#215; <italic toggle="yes">Rhazya stricta</italic></article-title><source>Chem. Pharm. Bull.</source><year>1996</year><volume>44</volume><fpage>1637</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1248/cpb.44.1637</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Aimi, N. et al. Isolation of alkaloids from cultured hybrid cells of <italic toggle="yes">Rauwolfia serpentina</italic> &#215; <italic toggle="yes">Rhazya stricta</italic>. <italic toggle="yes">Chem. Pharm. Bull.</italic>&#160;<bold>44</bold>, 1637&#8211;1639 (1996).</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achenbach</surname><given-names>H</given-names></name><name name-style="western"><surname>Benirschke</surname><given-names>M</given-names></name></person-group><article-title>Confirmation of the absolute configuration of Dolichantoside and isodolichantoside by synthesis from (&#8211;)-secologanin</article-title><source>Phytochemistry</source><year>1997</year><volume>44</volume><fpage>1387</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(96)00646-2</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Achenbach, H. &amp; Benirschke, M. Confirmation of the absolute configuration of Dolichantoside and isodolichantoside by synthesis from (&#8211;)-secologanin. <italic toggle="yes">Phytochemistry</italic><bold>44</bold>, 1387&#8211;1390 (1997).</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berger</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loganin and Secologanin derived tryptamine-iridoid alkaloids from <italic toggle="yes">Palicourea crocea</italic> and <italic toggle="yes">Palicourea Padifolia</italic> (Rubiaceae)</article-title><source>Phytochemistry</source><year>2015</year><volume>116</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2015.05.013</pub-id><pub-id pub-id-type="pmid">26043882</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Berger, A. et al. Loganin and Secologanin derived tryptamine-iridoid alkaloids from <italic toggle="yes">Palicourea crocea</italic> and <italic toggle="yes">Palicourea Padifolia</italic> (Rubiaceae). <italic toggle="yes">Phytochemistry</italic><bold>116</bold>, 162&#8211;169 (2015).<pub-id pub-id-type="pmid">26043882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phytochem.2015.05.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>LT</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>JN</given-names></name></person-group><article-title>Ki67 is a promising molecular target in the diagnosis of cancer (review)</article-title><source>Mol. Med. Rep.</source><year>2015</year><volume>11</volume><fpage>1566</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.3892/mmr.2014.2914</pub-id><pub-id pub-id-type="pmid">25384676</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Li, L. T., Jiang, G., Chen, Q. &amp; Zheng, J. N. Ki67 is a promising molecular target in the diagnosis of cancer (review). <italic toggle="yes">Mol. Med. Rep.</italic><bold>11</bold>, 1566&#8211;1572 (2015).<pub-id pub-id-type="pmid">25384676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2014.2914</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>CH</given-names></name><etal/></person-group><article-title>EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82</article-title><source>Biochim. Biophys. Acta</source><year>2015</year><volume>1852</volume><fpage>1540</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2015.04.020</pub-id><pub-id pub-id-type="pmid">25912735</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Yang, C. H. et al. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82. <italic toggle="yes">Biochim. Biophys. Acta</italic>. <bold>1852</bold>, 1540&#8211;1549 (2015).<pub-id pub-id-type="pmid">25912735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbadis.2015.04.020</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Chidamide alleviates TGF-&#946;-induced epithelial-mesenchymal transition in lung cancer cell lines</article-title><source>Mol. Biol. Rep.</source><year>2016</year><volume>43</volume><fpage>687</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1007/s11033-016-4005-z</pub-id><pub-id pub-id-type="pmid">27188428</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Lin, S. H. et al. Chidamide alleviates TGF-&#946;-induced epithelial-mesenchymal transition in lung cancer cell lines. <italic toggle="yes">Mol. Biol. Rep.</italic><bold>43</bold>, 687&#8211;695 (2016).<pub-id pub-id-type="pmid">27188428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11033-016-4005-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Advantages of restoring miR-205-3p expression for better prognosis of gastric cancer via prevention of epithelial-mesenchymal transition</article-title><source>J. Gastric Cancer</source><year>2020</year><volume>20</volume><fpage>212</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.5230/jgc.2020.20.e19</pub-id><pub-id pub-id-type="pmid">32596004</pub-id><pub-id pub-id-type="pmcid">PMC7311212</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Zhang, Z. et al. Advantages of restoring miR-205-3p expression for better prognosis of gastric cancer via prevention of epithelial-mesenchymal transition. <italic toggle="yes">J. Gastric Cancer</italic>&#160;<bold>20</bold>, 212&#8211;224 (2020).<pub-id pub-id-type="pmid">32596004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5230/jgc.2020.20.e19</pub-id><pub-id pub-id-type="pmcid">PMC7311212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells</article-title><source>BMC Cancer</source><year>2018</year><volume>18</volume><fpage>150</fpage><pub-id pub-id-type="doi">10.1186/s12885-018-4071-9</pub-id><pub-id pub-id-type="pmid">29409467</pub-id><pub-id pub-id-type="pmcid">PMC5801683</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Kim, S. H. et al. Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells. <italic toggle="yes">BMC Cancer</italic>. <bold>18</bold>, 150 (2018).<pub-id pub-id-type="pmid">29409467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-018-4071-9</pub-id><pub-id pub-id-type="pmcid">PMC5801683</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghandi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Next-generation characterization of the Cancer cell line encyclopedia</article-title><source>Nature</source><year>2019</year><volume>569</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1186-3</pub-id><pub-id pub-id-type="pmid">31068700</pub-id><pub-id pub-id-type="pmcid">PMC6697103</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Ghandi, M. et al. Next-generation characterization of the Cancer cell line encyclopedia. <italic toggle="yes">Nature</italic><bold>569</bold>, 503&#8211;508 (2019).<pub-id pub-id-type="pmid">31068700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-019-1186-3</pub-id><pub-id pub-id-type="pmcid">PMC6697103</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forbes</surname><given-names>SA</given-names></name><etal/></person-group><article-title>COSMIC: Exploring the world&#8217;s knowledge of somatic mutations in human cancer</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>D805</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1093/nar/gku1075</pub-id><pub-id pub-id-type="pmid">25355519</pub-id><pub-id pub-id-type="pmcid">PMC4383913</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Forbes, S. A. et al. COSMIC: Exploring the world&#8217;s knowledge of somatic mutations in human cancer. <italic toggle="yes">Nucleic Acids Res.</italic><bold>43</bold>, D805&#8211;811 (2015).<pub-id pub-id-type="pmid">25355519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1075</pub-id><pub-id pub-id-type="pmcid">PMC4383913</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Dong</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Qin</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Sauchinone prevents TGF-&#946;-induced EMT and metastasis in gastric cancer cells</article-title><source>Biomed. Pharmacother.</source><year>2018</year><volume>101</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.02.121</pub-id><pub-id pub-id-type="pmid">29499410</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">He, Z., Dong, W., Li, Q., Qin, C. &amp; Li, Y. Sauchinone prevents TGF-&#946;-induced EMT and metastasis in gastric cancer cells. <italic toggle="yes">Biomed. Pharmacother.</italic><bold>101</bold>, 355&#8211;361 (2018).<pub-id pub-id-type="pmid">29499410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2018.02.121</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albano</surname><given-names>F</given-names></name><etal/></person-group><article-title>Representing ECM composition and EMT pathways in gastric cancer using a new metastatic gene signature</article-title><source>Front. Cell. Dev. Biol.</source><year>2024</year><volume>12</volume><fpage>1481818</fpage><pub-id pub-id-type="doi">10.3389/fcell.2024.1481818</pub-id><pub-id pub-id-type="pmid">39563861</pub-id><pub-id pub-id-type="pmcid">PMC11573575</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Albano, F. et al. Representing ECM composition and EMT pathways in gastric cancer using a new metastatic gene signature. <italic toggle="yes">Front. Cell. Dev. Biol.</italic><bold>12</bold>, 1481818 (2024).<pub-id pub-id-type="pmid">39563861</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcell.2024.1481818</pub-id><pub-id pub-id-type="pmcid">PMC11573575</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmuck</surname><given-names>R</given-names></name><etal/></person-group><article-title>Genotypic and phenotypic characterization of side population of gastric cancer cell lines</article-title><source>Am. J. Pathol.</source><year>2011</year><volume>178</volume><fpage>1792</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2010.12.043</pub-id><pub-id pub-id-type="pmid">21435459</pub-id><pub-id pub-id-type="pmcid">PMC3078445</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Schmuck, R. et al. Genotypic and phenotypic characterization of side population of gastric cancer cell lines. <italic toggle="yes">Am. J. Pathol.</italic><bold>178</bold>, 1792&#8211;1804 (2011).<pub-id pub-id-type="pmid">21435459</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajpath.2010.12.043</pub-id><pub-id pub-id-type="pmcid">PMC3078445</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hidalgo</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Raub</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Borchardt</surname><given-names>RT</given-names></name></person-group><article-title>Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability</article-title><source>Gastroenterology</source><year>1989</year><volume>96</volume><fpage>736</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1016/S0016-5085(89)80072-1</pub-id><pub-id pub-id-type="pmid">2914637</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Hidalgo, I. J., Raub, T. J. &amp; Borchardt, R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. <italic toggle="yes">Gastroenterology</italic><bold>96</bold>, 736&#8211;749 (1989).<pub-id pub-id-type="pmid">2914637</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keemink</surname><given-names>J</given-names></name><name name-style="western"><surname>Bergstr&#246;m</surname><given-names>CAS</given-names></name></person-group><article-title>Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations</article-title><source>Pharm. Res.</source><year>2018</year><volume>35</volume><fpage>74</fpage><pub-id pub-id-type="doi">10.1007/s11095-017-2327-8</pub-id><pub-id pub-id-type="pmid">29484506</pub-id><pub-id pub-id-type="pmcid">PMC5847224</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Keemink, J. &amp; Bergstr&#246;m, C. A. S. Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations. <italic toggle="yes">Pharm. Res.</italic><bold>35</bold>, 74 (2018).<pub-id pub-id-type="pmid">29484506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11095-017-2327-8</pub-id><pub-id pub-id-type="pmcid">PMC5847224</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patankar</surname><given-names>M</given-names></name><name name-style="western"><surname>Eskelinen</surname><given-names>S</given-names></name><name name-style="western"><surname>Tuomisto</surname><given-names>A</given-names></name><name name-style="western"><surname>M&#228;kinen</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Karttunen</surname><given-names>TJ</given-names></name></person-group><article-title>KRAS and BRAF mutations induce Anoikis resistance and characteristic 3D phenotypes in Caco&#8211;2 cells</article-title><source>Mol. Med. Rep.</source><year>2019</year><volume>20</volume><fpage>4634</fpage><lpage>4644</lpage><pub-id pub-id-type="pmid">31545494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2019.10693</pub-id><pub-id pub-id-type="pmcid">PMC6797985</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Patankar, M., Eskelinen, S., Tuomisto, A., M&#228;kinen, M. J. &amp; Karttunen, T. J. KRAS and BRAF mutations induce Anoikis resistance and characteristic 3D phenotypes in Caco&#8211;2 cells. <italic toggle="yes">Mol. Med. Rep.</italic><bold>20</bold>, 4634&#8211;4644 (2019).<pub-id pub-id-type="pmid">31545494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2019.10693</pub-id><pub-id pub-id-type="pmcid">PMC6797985</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikonomou</surname><given-names>G</given-names></name><etal/></person-group><article-title>Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation</article-title><source>J. Proteomics</source><year>2012</year><volume>75</volume><fpage>5356</fpage><lpage>5369</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2012.06.038</pub-id><pub-id pub-id-type="pmid">22800643</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Ikonomou, G. et al. Interplay between oncogenic K-Ras and wild-type H-Ras in Caco2 cell transformation. <italic toggle="yes">J. Proteomics</italic>&#160;<bold>75</bold>, 5356&#8211;5369 (2012).<pub-id pub-id-type="pmid">22800643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jprot.2012.06.038</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>F Bodmer</surname><given-names>W</given-names></name></person-group><article-title>Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2006</year><volume>103</volume><fpage>976</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510146103</pub-id><pub-id pub-id-type="pmid">16418264</pub-id><pub-id pub-id-type="pmcid">PMC1327731</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Liu, Y. &amp; F Bodmer, W. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic><bold>103</bold>, 976&#8211;981 (2006).<pub-id pub-id-type="pmid">16418264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0510146103</pub-id><pub-id pub-id-type="pmcid">PMC1327731</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szklarczyk</surname><given-names>D</given-names></name><etal/></person-group><article-title>The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><fpage>D638</fpage><lpage>D646</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac1000</pub-id><pub-id pub-id-type="pmid">36370105</pub-id><pub-id pub-id-type="pmcid">PMC9825434</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Szklarczyk, D. et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. <italic toggle="yes">Nucleic Acids Res.</italic><bold>51</bold>, D638&#8211;D646 (2023).<pub-id pub-id-type="pmid">36370105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkac1000</pub-id><pub-id pub-id-type="pmcid">PMC9825434</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>JL</given-names></name></person-group><article-title>Focal adhesion kinase in integrin signaling</article-title><source>Matrix Biol.</source><year>1997</year><volume>16</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/S0945-053X(97)90008-1</pub-id><pub-id pub-id-type="pmid">9402009</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Guan, J. L. Focal adhesion kinase in integrin signaling. <italic toggle="yes">Matrix Biol.</italic><bold>16</bold>, 195&#8211;200 (1997).<pub-id pub-id-type="pmid">9402009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0945-053x(97)90008-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mushtaq</surname><given-names>U</given-names></name><name name-style="western"><surname>Bashir</surname><given-names>M</given-names></name><name name-style="western"><surname>Nabi</surname><given-names>S</given-names></name><name name-style="western"><surname>Khanday</surname><given-names>FA</given-names></name></person-group><article-title>Epidermal growth factor receptor and integrins Meet redox signaling through P66shc and Rac1</article-title><source>Cytokine</source><year>2021</year><volume>146</volume><fpage>155625</fpage><pub-id pub-id-type="doi">10.1016/j.cyto.2021.155625</pub-id><pub-id pub-id-type="pmid">34157521</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Mushtaq, U., Bashir, M., Nabi, S. &amp; Khanday, F. A. Epidermal growth factor receptor and integrins Meet redox signaling through P66shc and Rac1. <italic toggle="yes">Cytokine</italic><bold>146</bold>, 155625 (2021).<pub-id pub-id-type="pmid">34157521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cyto.2021.155625</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shankar</surname><given-names>J</given-names></name><name name-style="western"><surname>Nabi</surname><given-names>IR</given-names></name></person-group><article-title>Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0119954</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0119954</pub-id><pub-id pub-id-type="pmid">25756282</pub-id><pub-id pub-id-type="pmcid">PMC4355409</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Shankar, J. &amp; Nabi, I. R. Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells. <italic toggle="yes">PLoS ONE</italic>&#160;<bold>10</bold>, e0119954 (2015).<pub-id pub-id-type="pmid">25756282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0119954</pub-id><pub-id pub-id-type="pmcid">PMC4355409</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>H</given-names></name><name name-style="western"><surname>Dehart</surname><given-names>JP</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lim</surname><given-names>ST</given-names></name></person-group><article-title>Understanding the roles of FAK in cancer: Inhibitors, genetic models, and new insights</article-title><source>J. Histochem. Cytochem.</source><year>2015</year><volume>63</volume><fpage>114</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1369/0022155414561498</pub-id><pub-id pub-id-type="pmid">25380750</pub-id><pub-id pub-id-type="pmcid">PMC4305513</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Yoon, H., Dehart, J. P., Murphy, J. M. &amp; Lim, S. T. Understanding the roles of FAK in cancer: Inhibitors, genetic models, and new insights. <italic toggle="yes">J. Histochem. Cytochem.</italic><bold>63</bold>, 114&#8211;128 (2015).<pub-id pub-id-type="pmid">25380750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1369/0022155414561498</pub-id><pub-id pub-id-type="pmcid">PMC4305513</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>D</given-names></name><etal/></person-group><article-title>FAK regulates epithelial&#8211;mesenchymal transition in adenomyosis</article-title><source>Mol. Med. Rep.</source><year>2018</year><volume>18</volume><fpage>5461</fpage><lpage>5472</lpage><pub-id pub-id-type="pmid">30365102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2018.9600</pub-id><pub-id pub-id-type="pmcid">PMC6236295</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Zheng, D. et al. FAK regulates epithelial&#8211;mesenchymal transition in adenomyosis. <italic toggle="yes">Mol. Med. Rep.</italic><bold>18</bold>, 5461&#8211;5472 (2018).<pub-id pub-id-type="pmid">30365102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2018.9600</pub-id><pub-id pub-id-type="pmcid">PMC6236295</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurmagambetova</surname><given-names>A</given-names></name><name name-style="western"><surname>Mustyatsa</surname><given-names>V</given-names></name><name name-style="western"><surname>Saidova</surname><given-names>A</given-names></name><name name-style="western"><surname>Vorobjev</surname><given-names>I</given-names></name></person-group><article-title>Morphological and cytoskeleton changes in cells after EMT</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><fpage>22164</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-48279-y</pub-id><pub-id pub-id-type="pmid">38092761</pub-id><pub-id pub-id-type="pmcid">PMC10719275</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Nurmagambetova, A., Mustyatsa, V., Saidova, A. &amp; Vorobjev, I. Morphological and cytoskeleton changes in cells after EMT. <italic toggle="yes">Sci. Rep.</italic><bold>13</bold>, 22164 (2023).<pub-id pub-id-type="pmid">38092761</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-48279-y</pub-id><pub-id pub-id-type="pmcid">PMC10719275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baiula</surname><given-names>M</given-names></name><etal/></person-group><article-title>New &#946;-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins</article-title><source>J. Med. Chem.</source><year>2016</year><volume>59</volume><fpage>9721</fpage><lpage>9742</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.6b00576</pub-id><pub-id pub-id-type="pmid">27726366</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Baiula, M. et al. New &#946;-lactam derivatives modulate cell adhesion and signaling mediated by RGD-binding and leukocyte integrins. <italic toggle="yes">J. Med. Chem.</italic><bold>59</bold>, 9721&#8211;9742 (2016).<pub-id pub-id-type="pmid">27726366</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jmedchem.6b00576</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shishido</surname><given-names>S</given-names></name><name name-style="western"><surname>B&#246;nig</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YM</given-names></name></person-group><article-title>Role of integrin alpha4 in drug resistance of leukemia</article-title><source>Front. Oncol.</source><year>2014</year><volume>4</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.3389/fonc.2014.00099</pub-id><pub-id pub-id-type="pmid">24904821</pub-id><pub-id pub-id-type="pmcid">PMC4033044</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Shishido, S., B&#246;nig, H. &amp; Kim, Y. M. Role of integrin alpha4 in drug resistance of leukemia. <italic toggle="yes">Front. Oncol.</italic><bold>4</bold>, 99 (2014).<pub-id pub-id-type="pmid">24904821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2014.00099</pub-id><pub-id pub-id-type="pmcid">PMC4033044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><etal/></person-group><article-title>Integrin &#913;4 up-regulation activates the Hedgehog pathway to promote arsenic and benzo[&#945;]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis</article-title><source>Cancer Lett.</source><year>2020</year><volume>493</volume><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2020.08.015</pub-id><pub-id pub-id-type="pmid">32860851</pub-id><pub-id pub-id-type="pmcid">PMC9083130</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Xie, J. et al. Integrin &#913;4 up-regulation activates the Hedgehog pathway to promote arsenic and benzo[&#945;]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis. <italic toggle="yes">Cancer Lett.</italic><bold>493</bold>, 143&#8211;155 (2020).<pub-id pub-id-type="pmid">32860851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.canlet.2020.08.015</pub-id><pub-id pub-id-type="pmcid">PMC9083130</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulubova</surname><given-names>M</given-names></name><name name-style="western"><surname>Vlaykova</surname><given-names>T</given-names></name></person-group><article-title>Immunohistochemical assessment of fibronectin and Tenascin and their integrin receptors &#913;5&#946;1 and &#913;9&#946;1 in gastric and colorectal cancers with lymph node and liver metastases</article-title><source>Acta Histochem.</source><year>2006</year><volume>108</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.acthis.2005.12.001</pub-id><pub-id pub-id-type="pmid">16430945</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Gulubova, M. &amp; Vlaykova, T. Immunohistochemical assessment of fibronectin and Tenascin and their integrin receptors &#913;5&#946;1 and &#913;9&#946;1 in gastric and colorectal cancers with lymph node and liver metastases. <italic toggle="yes">Acta Histochem.</italic><bold>108</bold>, 25&#8211;35 (2006).<pub-id pub-id-type="pmid">16430945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.acthis.2005.12.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kornberg</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Earp</surname><given-names>HS</given-names></name><name name-style="western"><surname>Turner</surname><given-names>CE</given-names></name><name name-style="western"><surname>Prockop</surname><given-names>C</given-names></name><name name-style="western"><surname>Juliano</surname><given-names>RL</given-names></name></person-group><article-title>Signal transduction by integrins: Increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins</article-title><source>Proc. Natl. Acad. Sci. U. S. A</source><year>1991</year><volume>88</volume><fpage>8392</fpage><lpage>8396</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.19.8392</pub-id><pub-id pub-id-type="pmid">1717976</pub-id><pub-id pub-id-type="pmcid">PMC52514</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Kornberg, L. J., Earp, H. S., Turner, C. E., Prockop, C. &amp; Juliano, R. L. Signal transduction by integrins: Increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic><bold>88</bold>, 8392&#8211;8396 (1991).<pub-id pub-id-type="pmid">1717976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.88.19.8392</pub-id><pub-id pub-id-type="pmcid">PMC52514</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Huang, K. et al. Correlation between FAK and EGF-induced EMT in colorectal cancer cells. <italic toggle="yes">J. Oncol.</italic> 5428920 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/5428920</pub-id><pub-id pub-id-type="pmcid">PMC7048944</pub-id><pub-id pub-id-type="pmid">32148496</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tornin</surname><given-names>J</given-names></name><etal/></person-group><article-title>FUS-CHOP promotes invasion in myxoid liposarcoma through a SRC/FAK/RHO/ROCK-dependent pathway</article-title><source>Neoplasia</source><year>2018</year><volume>20</volume><fpage>44</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.neo.2017.11.004</pub-id><pub-id pub-id-type="pmid">29190494</pub-id><pub-id pub-id-type="pmcid">PMC5747526</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Tornin, J. et al. FUS-CHOP promotes invasion in myxoid liposarcoma through a SRC/FAK/RHO/ROCK-dependent pathway. <italic toggle="yes">Neoplasia</italic><bold>20</bold>, 44&#8211;56 (2018).<pub-id pub-id-type="pmid">29190494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neo.2017.11.004</pub-id><pub-id pub-id-type="pmcid">PMC5747526</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amano</surname><given-names>M</given-names></name><etal/></person-group><article-title>Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)</article-title><source>J. Biol. Chem.</source><year>1996</year><volume>271</volume><fpage>20246</fpage><lpage>20249</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.34.20246</pub-id><pub-id pub-id-type="pmid">8702756</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Amano, M. et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). <italic toggle="yes">J. Biol. Chem.</italic><bold>271</bold>, 20246&#8211;20249 (1996).<pub-id pub-id-type="pmid">8702756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.271.34.20246</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaibuchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuroda</surname><given-names>S</given-names></name><name name-style="western"><surname>Amano</surname><given-names>M</given-names></name></person-group><article-title>Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells</article-title><source>Annu. Rev. Biochem.</source><year>1999</year><volume>68</volume><fpage>459</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.68.1.459</pub-id><pub-id pub-id-type="pmid">10872457</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Kaibuchi, K., Kuroda, S. &amp; Amano, M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>68</bold>, 459&#8211;486 (1999).<pub-id pub-id-type="pmid">10872457</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.biochem.68.1.459</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title>The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro</article-title><source>Oncol. Rep.</source><year>2006</year><volume>15</volume><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="pmid">16596177</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Zhao, L. et al. The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro. <italic toggle="yes">Oncol. Rep.</italic><bold>15</bold>, 1147&#8211;1152 (2006).<pub-id pub-id-type="pmid">16596177</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Cancer stem cells: Advances in knowledge and implications for cancer therapy</article-title><source>Signal. Transduct. Target. Ther.</source><year>2024</year><volume>9</volume><fpage>170</fpage><pub-id pub-id-type="doi">10.1038/s41392-024-01851-y</pub-id><pub-id pub-id-type="pmid">38965243</pub-id><pub-id pub-id-type="pmcid">PMC11224386</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Chu, X. et al. Cancer stem cells: Advances in knowledge and implications for cancer therapy. <italic toggle="yes">Signal. Transduct. Target. Ther.</italic><bold>9</bold>, 170 (2024).<pub-id pub-id-type="pmid">38965243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-024-01851-y</pub-id><pub-id pub-id-type="pmcid">PMC11224386</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dart</surname><given-names>A</given-names></name></person-group><article-title>EMT in chemoresistance</article-title><source>Nat. Rev. Cancer</source><year>2023</year><volume>23</volume><fpage>349</fpage><pub-id pub-id-type="doi">10.1038/s41568-023-00581-7</pub-id><pub-id pub-id-type="pmid">37106250</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Dart, A. EMT in chemoresistance. <italic toggle="yes">Nat. Rev. Cancer</italic>&#160;<bold>23</bold>, 349 (2023).<pub-id pub-id-type="pmid">37106250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41568-023-00581-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pradella</surname><given-names>D</given-names></name><name name-style="western"><surname>Naro</surname><given-names>C</given-names></name><name name-style="western"><surname>Sette</surname><given-names>C</given-names></name><name name-style="western"><surname>Ghigna</surname><given-names>C</given-names></name></person-group><article-title>EMT and stemness: Flexible processes tuned by alternative splicing in development and cancer progression</article-title><source>Mol. Cancer</source><year>2017</year><volume>16</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s12943-016-0579-2</pub-id><pub-id pub-id-type="pmid">28137272</pub-id><pub-id pub-id-type="pmcid">PMC5282733</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Pradella, D., Naro, C., Sette, C. &amp; Ghigna, C. EMT and stemness: Flexible processes tuned by alternative splicing in development and cancer progression. <italic toggle="yes">Mol. Cancer</italic>&#160;<bold>16</bold>, 8 (2017).<pub-id pub-id-type="pmid">28137272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12943-016-0579-2</pub-id><pub-id pub-id-type="pmcid">PMC5282733</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>S</given-names></name><name name-style="western"><surname>Sunkara</surname><given-names>RR</given-names></name><name name-style="western"><surname>Parmar</surname><given-names>MY</given-names></name><name name-style="western"><surname>Shaikh</surname><given-names>S</given-names></name><name name-style="western"><surname>Waghmare</surname><given-names>SK</given-names></name></person-group><article-title>EMT imparts cancer stemness and plasticity: New perspectives and therapeutic potential</article-title><source>Front. Biosci.</source><year>2021</year><volume>26</volume><fpage>238</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.2741/4893</pub-id><pub-id pub-id-type="pmid">33049669</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Roy, S., Sunkara, R. R., Parmar, M. Y., Shaikh, S. &amp; Waghmare, S. K. EMT imparts cancer stemness and plasticity: New perspectives and therapeutic potential. <italic toggle="yes">Front. Biosci. </italic><bold>26</bold>, 238&#8211;265 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.2741/4893</pub-id><pub-id pub-id-type="pmid">33049669</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="other">Zhou, C. et al. ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3. <italic toggle="yes">Oncotarget</italic><bold>8</bold>, 54388&#8211;54401 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.17077</pub-id><pub-id pub-id-type="pmcid">PMC5589589</pub-id><pub-id pub-id-type="pmid">28903350</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="other">Khales, S. A, Mozaffari-Jovin, S., Geerts, D. &amp; Abbaszadegan, M. R. TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma. <italic toggle="yes">BMC Cancer</italic><bold>22</bold>, 1272 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12885-022-10252-9</pub-id><pub-id pub-id-type="pmcid">PMC9724315</pub-id><pub-id pub-id-type="pmid">36474162</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="other">Luanpitpong, S. et al. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma. <italic toggle="yes">Oncogene</italic><bold>35</bold>, 2824&#8211;2833 (2016).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/onc.2015.351</pub-id><pub-id pub-id-type="pmcid">PMC4801727</pub-id><pub-id pub-id-type="pmid">26387547</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Storr</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Carragher</surname><given-names>NO</given-names></name><name name-style="western"><surname>Frame</surname><given-names>MC</given-names></name><name name-style="western"><surname>Parr</surname><given-names>T</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SG</given-names></name></person-group><article-title>The Calpain system and cancer</article-title><source>Nat. Rev. Cancer</source><year>2011</year><volume>11</volume><fpage>364</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/nrc3050</pub-id><pub-id pub-id-type="pmid">21508973</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Storr, S. J., Carragher, N. O., Frame, M. C., Parr, T. &amp; Martin, S. G. The Calpain system and cancer. <italic toggle="yes">Nat. Rev. Cancer</italic>&#160;<bold>11</bold>, 364&#8211;374 (2011).<pub-id pub-id-type="pmid">21508973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc3050</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>N</given-names></name><etal/></person-group><article-title>Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways</article-title><source>Biochim. Biophys. Acta Mol. Cell. Res.</source><year>2017</year><volume>1864</volume><fpage>12</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.10.013</pub-id><pub-id pub-id-type="pmid">27773611</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Xiong, N. et al. Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways. <italic toggle="yes">Biochim. Biophys. Acta Mol. Cell. Res.</italic><bold>1864</bold>, 12&#8211;22 (2017).<pub-id pub-id-type="pmid">27773611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbamcr.2016.10.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>8210</fpage><lpage>8220</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-0343</pub-id><pub-id pub-id-type="pmid">18922892</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Joshi, B. et al. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. <italic toggle="yes">Cancer Res.</italic><bold>68</bold>, 8210&#8211;8220 (2008).<pub-id pub-id-type="pmid">18922892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-08-0343</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stradal</surname><given-names>TEB</given-names></name><etal/></person-group><article-title>Regulation of actin dynamics by WASP and WAVE family proteins</article-title><source>Trends Cell. Biol.</source><year>2004</year><volume>14</volume><fpage>303</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2004.04.007</pub-id><pub-id pub-id-type="pmid">15183187</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Stradal, T. E. B. et al. Regulation of actin dynamics by WASP and WAVE family proteins. <italic toggle="yes">Trends Cell. Biol.</italic><bold>14</bold>, 303&#8211;311 (2004).<pub-id pub-id-type="pmid">15183187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tcb.2004.04.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghoshal</surname><given-names>P</given-names></name><name name-style="western"><surname>Teng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lesoon</surname><given-names>LA</given-names></name><name name-style="western"><surname>Cowell</surname><given-names>JK</given-names></name></person-group><article-title>HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions</article-title><source>Int. J. Cancer</source><year>2012</year><volume>131</volume><fpage>E905</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1002/ijc.27631</pub-id><pub-id pub-id-type="pmid">22581642</pub-id><pub-id pub-id-type="pmcid">PMC3629704</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Ghoshal, P., Teng, Y., Lesoon, L. A. &amp; Cowell, J. K. HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions. <italic toggle="yes">Int. J. Cancer</italic>&#160;<bold>131</bold>, E905&#8211;915 (2012).<pub-id pub-id-type="pmid">22581642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.27631</pub-id><pub-id pub-id-type="pmcid">PMC3629704</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>XP</given-names></name><etal/></person-group><article-title>NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma</article-title><source>Cell. Death Dis.</source><year>2019</year><volume>10</volume><fpage>369</fpage><pub-id pub-id-type="doi">10.1038/s41419-019-1603-4</pub-id><pub-id pub-id-type="pmid">31068575</pub-id><pub-id pub-id-type="pmcid">PMC6506474</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Zhong, X. P. et al. NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma. <italic toggle="yes">Cell. Death Dis.</italic><bold>10</bold>, 369 (2019).<pub-id pub-id-type="pmid">31068575</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-019-1603-4</pub-id><pub-id pub-id-type="pmcid">PMC6506474</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hidalgo-Sastre</surname><given-names>A</given-names></name><etal/></person-group><article-title>Loss of Wasl improves pancreatic cancer outcome</article-title><source>JCI Insight</source><year>2020</year><volume>5</volume><fpage>e127275</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.127275</pub-id><pub-id pub-id-type="pmid">32434991</pub-id><pub-id pub-id-type="pmcid">PMC7259520</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Hidalgo-Sastre, A. et al. Loss of Wasl improves pancreatic cancer outcome. <italic toggle="yes">JCI Insight</italic>&#160;<bold>5</bold>, e127275 (2020).<pub-id pub-id-type="pmid">32434991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/jci.insight.127275</pub-id><pub-id pub-id-type="pmcid">PMC7259520</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><etal/></person-group><article-title>Anti-inflammatory effect of the six compounds isolated from <italic toggle="yes">Nauclea officinalis</italic> Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-&#954;B and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>196</volume><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.12.007</pub-id><pub-id pub-id-type="pmid">27989509</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Li, D. et al. Anti-inflammatory effect of the six compounds isolated from <italic toggle="yes">Nauclea officinalis</italic> Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-&#954;B and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>196</bold>, 66&#8211;74 (2017).<pub-id pub-id-type="pmid">27989509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2016.12.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) model</article-title><source>J. Physiol. Biochem.</source><year>2021</year><volume>77</volume><fpage>283</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1007/s13105-021-00796-y</pub-id><pub-id pub-id-type="pmid">33595775</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Jia, Q. et al. Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) model. <italic toggle="yes">J. Physiol. Biochem.</italic><bold>77</bold>, 283&#8211;294 (2021).<pub-id pub-id-type="pmid">33595775</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13105-021-00796-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aderibigbe</surname><given-names>SA</given-names></name><name name-style="western"><surname>Idowu</surname><given-names>SO</given-names></name><name name-style="western"><surname>Olaniyi</surname><given-names>AA</given-names></name><name name-style="western"><surname>Wright</surname><given-names>CW</given-names></name><name name-style="western"><surname>Fatokun</surname><given-names>AA</given-names></name></person-group><article-title>Bioactivity and cytotoxicity profiling of Vincosamide and Strictosamide, anthelmintic epimers from <italic toggle="yes">Sarcocephalus latifolius</italic> (Smith) Bruce leaf</article-title><source>J. Ethnopharmacol.</source><year>2021</year><volume>265</volume><fpage>113142</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.113142</pub-id><pub-id pub-id-type="pmid">32697959</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Aderibigbe, S. A., Idowu, S. O., Olaniyi, A. A., Wright, C. W. &amp; Fatokun, A. A. Bioactivity and cytotoxicity profiling of Vincosamide and Strictosamide, anthelmintic epimers from <italic toggle="yes">Sarcocephalus latifolius</italic> (Smith) Bruce leaf. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>265</bold>, 113142 (2021).<pub-id pub-id-type="pmid">32697959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2020.113142</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rojas-Duran</surname><given-names>R</given-names></name><etal/></person-group><article-title>Anti-inflammatory activity of mitraphylline isolated from <italic toggle="yes">Uncaria tomentosa</italic> bark</article-title><source>J. Ethnopharmacol.</source><year>2012</year><volume>143</volume><fpage>801</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.07.015</pub-id><pub-id pub-id-type="pmid">22846434</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Rojas-Duran, R. et al. Anti-inflammatory activity of mitraphylline isolated from <italic toggle="yes">Uncaria tomentosa</italic> bark. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>143</bold>, 801&#8211;804 (2012).<pub-id pub-id-type="pmid">22846434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2012.07.015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>la Montserrat-de</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pharmacological effects of mitraphylline from <italic toggle="yes">Uncaria tomentosa</italic> in primary human monocytes: Skew toward M2 macrophages</article-title><source>J. Ethnopharmacol.</source><year>2015</year><volume>170</volume><fpage>128</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.05.002</pub-id><pub-id pub-id-type="pmid">25975515</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">la Montserrat-de, S. et al. Pharmacological effects of mitraphylline from <italic toggle="yes">Uncaria tomentosa</italic> in primary human monocytes: Skew toward M2 macrophages. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>170</bold>, 128&#8211;135 (2015).<pub-id pub-id-type="pmid">25975515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2015.05.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other">Ahmad, R. &amp; Salim, F. Oxindole Alkaloids of <italic toggle="yes">Uncaria</italic> (Rubiaceae, Subfamily Cinchonoideae). In <italic toggle="yes">Studies In Natural Products Chemistry</italic> 485&#8211;525 (Elsevier, 2015).</mixed-citation></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Unnatural spirocyclic oxindole alkaloids biosynthesis in <italic toggle="yes">Uncaria Guianensis</italic></article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>11349</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-47706-3</pub-id><pub-id pub-id-type="pmid">31383908</pub-id><pub-id pub-id-type="pmcid">PMC6683290</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Lopes, A. A. et al. Unnatural spirocyclic oxindole alkaloids biosynthesis in <italic toggle="yes">Uncaria Guianensis</italic>. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 11349 (2019).<pub-id pub-id-type="pmid">31383908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-47706-3</pub-id><pub-id pub-id-type="pmcid">PMC6683290</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sambuy</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics</article-title><source>Cell. Biol. Toxicol.</source><year>2005</year><volume>21</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/s10565-005-0085-6</pub-id><pub-id pub-id-type="pmid">15868485</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Sambuy, Y. et al. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. <italic toggle="yes">Cell. Biol. Toxicol.</italic><bold>21</bold>, 1&#8211;26 (2005).<pub-id pub-id-type="pmid">15868485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10565-005-0085-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hilgendorf</surname><given-names>C</given-names></name><etal/></person-group><article-title>Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport</article-title><source>J. Pharm. Sci.</source><year>2000</year><volume>89</volume><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1520-6017(200001)89:1&amp;#x0003c;63::AID-JPS7&amp;#x0003e;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">10664539</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Hilgendorf, C. et al. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. <italic toggle="yes">J. Pharm. Sci.</italic><bold>89</bold>, 63&#8211;75 (2000).<pub-id pub-id-type="pmid">10664539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1520-6017(200001)89:1&lt;63::AID-JPS7&gt;3.0.CO;2-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laus</surname><given-names>G</given-names></name><name name-style="western"><surname>Br&#246;ssner</surname><given-names>D</given-names></name><name name-style="western"><surname>Senn</surname><given-names>G</given-names></name><name name-style="western"><surname>Wurst</surname><given-names>K</given-names></name></person-group><article-title>Analysis of the kinetics of isomerization of Spiro oxindole alkaloids</article-title><source>J. Chem. Soc. Perkin Trans.</source><year>1996</year><volume>2</volume><fpage>1931</fpage><lpage>1936</lpage><pub-id pub-id-type="doi">10.1039/P29960001931</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Laus, G., Br&#246;ssner, D., Senn, G. &amp; Wurst, K. Analysis of the kinetics of isomerization of Spiro oxindole alkaloids. <italic toggle="yes">J. Chem. Soc. Perkin Trans.</italic><bold>2</bold>, 1931&#8211;1936 (1996).</mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>